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A B S T R A C T
Background
Intracranial vascular malformations (brain or pial/dural arteriovenous malformations/fistulae, and aneurysms) are the leading cause of
intracerebral haemorrhage (ICH) in young adults. Early identification of the intracranial vascular malformation may improve outcome
if treatment can prevent ICH recurrence. Catheter intra-arterial digital subtraction angiography (IADSA) is considered the reference
standard for the detection an intracranial vascular malformation as the cause of ICH. Computed tomography angiography (CTA) and
magnetic resonance angiography (MRA) are less invasive than IADSA and may be as accurate for identifying some causes of ICH.
Objectives
To evaluate the diagnostic test accuracy of CTA and MRA versus IADSA for the detection of intracranial vascular malformations as a
cause of ICH.
Search methods
We searchedMEDLINE (1948 toAugust 2013), EMBASE (1980 toAugust 2013),MEDION (August 2013), theDatabase of Abstracts
of Reviews of Effects (DARE; August 2013), the Health Technology Assessment Database (HTA; August 2013), ClinicalTrials.gov
(August 2013), and WHO ICTRP (International Clinical Trials Register Portfolio; August 2013). We also performed a cited reference
search for forward tracking of relevant articles on Google Scholar (http://scholar.google.com/), screened bibliographies, and contacted
authors to identify additional studies.
Selection criteria
We selected studies reporting data that could be used to construct contingency tables that compared CTA or MRA, or both, with
IADSA in the same patients for the detection of intracranial vascular malformations following ICH.
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Data collection and analysis
Two authors (CBJ and RA-SS) independently extracted data on study characteristics and measures of test accuracy. Two authors (CBJ
and PMW) independently extracted data on test characteristics. We obtained data restricted to the subgroup undergoing IADSA in
studies using multiple reference standards. We combined data using the bivariate model. We generated forest plots of the sensitivity
and specificity of CTA and MRA and created a summary receiver operating characteristic plot.
Main results
Eleven studies (n = 927 participants) met our inclusion criteria. Eight studies compared CTA with IADSA (n = 526) and three studies
compared MRA with IADSA (n = 401). Methodological quality varied considerably among studies, with partial verification bias in 7/
11 (64%) and retrospective designs in 5/10 (50%). In studies of CTA, the pooled estimate of sensitivity was 0.95 (95% confidence
interval (CI) 0.90 to 0.97) and specificity was 0.99 (95% CI 0.95 to 1.00). The results remained robust in a sensitivity analysis in
which only studies evaluating adult patients (≥ 16 years of age) were included. In studies of MRA, the pooled estimate of sensitivity
was 0.98 (95% CI 0.80 to 1.00) and specificity was 0.99 (95% CI 0.97 to 1.00). An indirect comparison of CTA and MRA using
a bivariate model incorporating test type as one of the parameters failed to reveal a statistically significant difference in sensitivity or
specificity between the two imaging modalities (P value = 0.6).
Authors’ conclusions
CTA and MRA appear to have good sensitivity and specificity following ICH for the detection of intracranial vascular malformations,
although several of the included studies hadmethodological shortcomings (retrospective designs andpartial verification bias in particular)
that may have increased apparent test accuracy.
P L A I N L A N G U A G E S U M M A R Y
Computed tomography angiography or magnetic resonance angiography for detecting blood vessel abnormalities in patients
with intracerebral haemorrhage
Blood vessel abnormalities are the leading cause of bleeding in the brain (known as intracerebral haemorrhage) in young adults. Early
detection of blood vessel abnormalities may improve outcome if treatment can prevent bleeding recurrence. This review looked at
different tests used to identify blood vessel abnormalities in the brain. Intra-arterial digital subtraction angiography (IADSA) is the
standard test used and involves positioning a tube, introduced through a blood vessel in the groin, into blood vessels near the brain. Dye
is directly injected into the brain’s blood vessels using this tube. Computed tomographic angiography (CTA) and magnetic resonance
angiography (MRA) are newer tests that may be done without any injections (MRA) or only through an injection into the arm (CTA
and MRA). This review investigated the accuracy of CTA or MRA, or both, compared with IADSA after intracerebral haemorrhage.
We found eight studies (involving 526 participants) that compared CTA with IADSA and three studies (involving 401 participants)
that compared MRA with IADSA. Both CTA and MRA appear to have good accuracy when compared with IADSA. However, the
studies were small and were limited in many cases by their design. Further research that looks at accuracy, practicality, and costs is
needed.
B A C K G R O U N D
A stroke is a clinical syndrome characterised by a sudden loss of
focal brain function causing symptoms that last more than 24
hours or lead to death. Strokes occur either because of inadequate
blood supply to the brain (ischaemic stroke) or because of bleeding.
Bleeding can be between the membranous layers that surround
the brain or into the ventricles of the brain. However, bleeding
directly into the brain substance (intracerebral haemorrhage or
ICH) is a particularly devastating form of stroke. It accounts for
10% to 15% of all strokes in Caucasian populations (Lovelock
2007) and the one-month case fatality is approximately 40% (Van
Asch 2010).
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It is extremely important to make the distinction between ICH
and other forms of stroke since the causes, prognosis, and treat-
ment vary according to each condition.No clinical scoring systems
have yet been shown to be accurate in distinguishing between these
entities. Therefore, timely brain imaging is required to differen-
tiate ICH from ischaemic stroke and the other forms of haem-
orrhagic stroke (Al-Shahi Salman 2009). Computed tomography
(CT) andmagnetic resonance imaging (MRI) have both been used
in clinical practice. A Cochrane review of diagnostic test accuracy
has confirmed the utility of CT for detecting acute haemorrhagic
stroke but has concluded that insufficient information exists to
establish the merits of MRI for this purpose (Brazzelli 2009).
If a scan demonstrates ICH, the priority shifts to investigating the
cause of the bleed in order to estimate prognosis and direct treat-
ment. Physicians tend to infer the cause of ICH on the basis of the
patient’s age, co-morbidities, and ICH characteristics on CT or
MRI. For instance, elderly patients with preceding hypertension
and ICH in a ’deep’ location in the brain are often assumed to
have had a bleed unrelated to any underlying structural abnormal-
ity, while young patients with ’deep’ ICH and no past history of
high blood pressure are often investigated for an underlying vas-
cular malformation (Cordonnier 2010). However, these assump-
tions may be inaccurate (Cordonnier 2010). Additional history,
laboratory investigations, and sophisticated radiological tests may
help to establish the cause of ICH.
Target condition being diagnosed
Intracranial vascular malformations are of particular importance
as they are the leading cause of ICH in young adults (explaining
as many as one-third of cases in young people; Al-Shahi 2001)
and cause an appreciable proportion of ICH in older people (18%
(95% CI 13% to 24%) of cases in people aged ≥ 50 in a recent
systematic review; Cordonnier 2010). Intracranial vascular mal-
formations include arteriovenous malformations, dural arteriove-
nous fistulae, and aneurysms (which are the target conditions in
this review). Arteriovenous malformations are abnormal tangles of
dilated arteries and veins of varying calibre that lack an interven-
ing capillary network. The arteries and veins are connected in a
central nidus (Latin nidus, nest). The lack of capillaries results in
direct arteriovenous shunting from the high-pressure arterial sys-
tem to the low-pressure venous system, which is not designed to
accommodate radical fluctuations in pulse pressure. A dural arte-
riovenous fistula is similar to an arteriovenous malformation but is
a direct, high-flow fistula between the external carotid circulation
and a dural venous sinus or cerebral cortical vein. An aneurysm
is a weakened, focal protrusion of the arterial wall that is often
found at a branching point of the cerebral blood vessels. These
three types of vascular malformations confer appreciable risks of
recurrent ICH, can be identified in the acute stages of ICH with
brain imaging, and are often amenable to treatment intended to
prevent rebleeding.
The traditional reference standard for diagnosing arteriovenous
malformations, dural arteriovenous fistulae, and aneurysms is
catheter intra-arterial digital subtraction angiography (IADSA).
This involves inserting a catheter into the femoral artery and guid-
ing it back through the arterial circulation to the common, inter-
nal, or external carotid arteries or into the vertebral arteries. Pre-
contrast x-ray images (the ’mask’) are taken and then contrast dye
is injected from the catheter into the cerebral artery in which it
is positioned. Further images are taken during injection and the
mask is then subtracted from the post-contrast images. All that
remains should be the blood vessels that were filled with contrast
material. Images are taken in quick succession during the injection
so that radiologists can evaluate blood flow through the arterial
system into the venous system. Arteriovenous malformations are
typically visualised on IADSA as tangles of abnormal vessels with
enlarged feeding arteries and dilated, tortuous veins within the
brain substance. Early venous filling during the arterial phase of
contrast injection is characteristic of arteriovenous malformations.
Dural arteriovenous fistulae appear as early venous filling during
the arterial phase of contrast injection via direct connections be-
tween dural arteries and a venous sinus or cortical veins within
the dura mater covering of the brain. Aneurysms are visualised on
IADSA as contrast-filled outpouchings that arise from an arterial
wall or bifurcation, although thrombosed aneurysms may be more
difficult to appreciate if there is limited contrast penetration.
Given the disparity in the prevalence of moya-moya disease be-
tween Asian and non-Asian populations (Scott 2009), we decided
to exclude this condition as ethnicities are likely to vary within
and between studies.
Index test(s)
Although IADSA has been used to diagnose these target condi-
tions in the past, CT- and MRI-based techniques are becoming
increasingly popular in clinical practice. CT scanners use x-rays
to create a series of cross-sectional images of the brain. CT is very
useful for identifying acute haemorrhage but cannot reliably de-
tect vascular malformations due to its inability to discriminate
blood vessels clearly from the surrounding brain substance. MRI
uses the electromagnetic properties of protons to produce high-
quality cross-sectional images of the brain. Blood vessels are better
appreciated on MRI as characteristic ’flow voids’.
More advanced CT andMRI techniques have recently been devel-
oped to image blood vessels separately from the brain. CT angiog-
raphy (CTA) and MR angiography (MRA) exploit CT and MRI
techniques to create high-resolution images of the arteries of the
brain that can be used to diagnose arteriovenous malformations,
dural arteriovenous fistulae, and aneurysms. Both tests combine
sophisticated imaging techniques, sometimes involving a precisely
timed contrast infusion, to accentuate blood vessels during either
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the arterial or venous phase of contrast perfusion. Hundreds to
thousands of images are obtained and reconstructed in a variety
of planes so that blood vessels can be visualised in two and three
dimensions.
Neither CTA nor MRA is known to be superior to the other. Cur-
rently the choice of test ultimately depends on its availability and
the patient’s ability to undergo the test; for example, patients may
have contraindications to MRA or they may be unable to lie still
for IADSA under local anaesthetic. The timing of these tests in
relation to the ICH onset may influence diagnostic test accuracy,
because the mass effect of ICH may obscure the underlying in-
tracranial vascular malformation. Repeat IADSA, three or more
weeks following ICH onset, can detect arteriovenous malforma-
tions that were missed on an initial IADSA performed during the
acute stages of the bleed (Hino 1998).
Rationale
In patients who present to hospital with ICH, the swift and ac-
curate identification of any underlying intracranial vascular mal-
formation that may be the underlying cause is important. For in-
stance, patients with ICH caused by arteriovenous malformations
seem to fare better than their counterparts with ’primary’ ICH,
even after adjusting for known prognostic factors (Van Beijnum
2009). Early and accurate diagnosis could improve outcome if
treatment prevents recurrent haemorrhage.
Catheter IADSA is the conventional reference standard technique
for the diagnosis of arteriovenous malformations, dural arteriove-
nous fistulae, and aneurysms. However, IADSA is not available in
all centres and, because a catheter is required for the procedure, it
carries a small but significant risk of stroke, infection, haematoma
formation at the catheter entry site, and pseudo-aneurysm forma-
tion at the femoral artery puncture site. As a result of their widen-
ing availability, lower procedural risks, increasing resolution, and
sophisticated reconstruction software, CTA and MRA are often
used prior to, or instead of, IADSA in patients with a suspected
intracranial vascular malformation following different types of in-
tracranial haemorrhage.
Systematic reviews andmeta-analyses have already been performed
to determine how the diagnostic accuracy of CTA andMRA com-
pares with IADSA for the detection of aneurysms following sub-
arachnoid haemorrhage (bleeding between the arachnoid and pial
meningeal layers that surround the brain) (White 2000; Chappell
2003; Van Gelder 2003; Westerlaan 2011). When we registered
our title and protocol for this Cochrane systematic review, there
were no meta-analyses of the diagnostic test accuracy of CTA and
MRA versus IADSA following ICH. However, two systematic re-
views have recently emerged (Ma 2012; Wong 2012), although
they did not restrict data to the same reference standard (IADSA).
Each review used different inclusion criteria and neither analysed
MRA. The quality of included studies were not systematically as-
sessed using validated measures such as the Quality Assessment
of Diagnostic Accuracy Studies (QUADAS) tool, heterogeneity
among included studies was not analysed in one review (Wong
2012), and the target conditions differed from those evaluated in
our analysis. Therefore, we systematically reviewed the literature
for studies of the diagnostic accuracy of CTA or MRA compared
with IADSA as a reference standard for the detection of intracra-
nial vascular malformations underlying ICH.
O B J E C T I V E S
To evaluate the diagnostic test accuracy of CTA and MRA versus
IADSA for the detection of intracranial vascular malformations as
a cause of ICH.
Secondary objectives
To investigate the influence of the timingof the index and reference
tests on diagnostic test accuracy.
Investigation of sources of heterogeneity
We planned to investigate the differences in diagnostic accuracy
in subgroups defined by:
• age;
• ICH volume;
• timing of the index test(s) after symptom onset;
• CT technology (for example non-helical CT scanners,
helical CT scanners, and multi-detector helical CT scanners) and
MRI technology (for example MRI magnet strength and the
type of angiographic technique used to image the arteries);
• the coverage of the brain that is investigated by CTA/MRA
in each study (e.g. some users may only evaluate the region
around the haematoma while others may choose to also evaluate
vessels distant from the bleed);
• the number of arterial territories and orientations
investigated by IADSA (e.g. the internal carotid artery territory,
the external carotid artery territory, the vertebral artery territory,
or all three);
• whether three-dimensional angiography was used;
• differences in the qualifications and experience of the
radiologists reporting the index tests and reference standards.
M E T H O D S
Criteria for considering studies for this review
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Types of studies
Single or comparative test accuracy studies of CTA or MRA, or
both (index tests) versus IADSA (reference standard) in patients
with radiographically verified ICH were eligible for inclusion as
long as participants underwent at least one index test as well as the
reference standard. We included retrospective and prospective case
series and cohort studies of consecutive patients (Gluud 2005),
irrespective of their date of publication, country, or language of
origin. There were no restrictions based on the medical setting in
which the tests were performed.We set a minimum overall sample
size per study of 20 or more participants. We accepted studies that
had fewer than 20 individuals undergoing IADSA as long as the
overall study size was greater than 20 participants.
Participants
We included all participants with ICH (as defined by study au-
thors), who were investigated with one or more index tests and a
reference standard. Participants were included irrespective of the
severity of their disease as long as they were stable enough to un-
dergo an index test and a reference standard.
Index tests
We assessed the following index tests.
1. Computed tomography angiography (CTA).
2. Magnetic resonance angiography (contrast enhanced or
non-enhanced) (MRA).
Comparator tests
We sought single test accuracy studies that evaluatedCTAorMRA
against the IADSA reference standard, as well as comparative stud-
ies of CTA versus MRA against the IADSA reference standard.
Target conditions
The target conditions were aneurysms, arteriovenous malforma-
tions, or pial/dural arteriovenous fistulae that have caused ICH.
We re-classified patients with moya-moya as ’non-diseased’ for the
purposes of the review.
Reference standards
A single reference standard for the diagnosis of intracranial vas-
cular malformations does not exist. In clinical practice, however,
expert assessment of IADSA is considered the most valid test and
therefore we only included studies that used this test as the ref-
erence standard in the review. If studies had used more than one
reference standard, we only included these studies if they provided
data on patients who had been investigated with IADSA.
Search methods for identification of studies
Electronic searches
We searched the following electronic bibliographic databases.
• MEDLINE (Ovid) (1948 to August 2013) (Appendix 1).
• EMBASE (Ovid) (1980 to August 2013) (Appendix 2).
• Database of Abstracts of Reviews of Effects (DARE) (
www.crd.york.ac.uk/crdweb/) (August 2013).
• Health Technology Assessment Database (HTA) (
www.crd.york.ac.uk/crdweb/) (August 2013).
• MEDION (www.mediondatabase.nl/) (August 2013) using
the ’Systematic Reviews and Diagnostic Studies’ search filter, the
ICPC code = ’Neurological’ and the signssymp = ’Medical
Imaging’.
• ClinicalTrials.gov (August 2013).
• WHO ICTRP (International Clinical Trials Register
Portfolio) (August 2013).
We developed comprehensive search strategies forMEDLINE and
EMBASE with the help of the Cochrane Stroke Group Infor-
mation Specialist and adapted these for the other databases. We
searched for all relevant studies and did not restrict our searches
by date, institution, or language.
Searching other resources
We searched the reference lists and performed a cited reference
search for forward tracking of relevant articles on Google Scholar
(http://scholar.google.com/) (August 2013) for all articles that we
reviewed for eligibility during the full-text review phase.
Data collection and analysis
Selection of studies
One author (CBJ) reviewed titles and abstracts of the records iden-
tified from the electronic searches and excluded obviously irrele-
vant citations. We then obtained the full copy of the remaining
papers and the same author together with a second review author
(PMW or RA-SS) assessed these to identify relevant studies that
met the inclusion criteria for the review. If there was any uncer-
tainty about a study’s eligibility we reached a decision through
discussion. If there was still uncertainty, we contacted the study
authors to ask them to provide the relevant information necessary
to resolve the uncertainty. We were not blinded to study authors,
institution, and study results during the selection process.
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Data extraction and management
Two of three review authors (CBJ and PMW or RA-SS) indepen-
dently extracted data using a standardised data collection form.
We accepted the authors’ definitions of a positive index/compara-
tor/reference test result for arteriovenous malformations, dural ar-
teriovenous fistulae, and aneurysms.
The absolute numbers of observations of true positives, false posi-
tives, true negatives, and false negatives had to be specified or had
to be able to be derived from the available data in order to be for-
mally meta-analysed. We contacted study authors if this was not
possible; if these data could not be obtained, despite contacting
the authors, then we excluded the study. We excluded studies if
they were a reanalysis or republication of data from a study pop-
ulation that was already included in the review.
We compared the data abstracted by two review authors (CBJ and
PMW or RA-SS) and resolved any disagreements through discus-
sion. We used the extracted raw data to construct 2 x 2 contin-
gency tables for outcomes defined as any of the target conditions
detected. We used the 2 x 2 contingency tables to calculate sen-
sitivity and specificity for each index test in all included studies
using RevMan 5.2 (RevMan 2012).
We extracted the following additional study-level attributes.
1. General information: title, journal (including volume and
pages), year, institution and country, language, and study design.
2. Population sampling: number of participants screened,
number eligible, number enrolled, and number undergoing both
the index tests (CTA or MRA, or both) and the reference
standard (IADSA).
3. Demographic characteristics: participant age, ethnicity,
number with pre-existing hypertension, number with a prior
intracranial haemorrhage.
4. Radiological description of the ICH: volume, location, and
extension of the intracerebral haemorrhage.
5. Index test parameters for: (1) CTA: manufacturer and
model, equipment (non-helical CT, helical CT, or multi-detector
CT), slice thickness, pitch, matrix, field of view, coverage,
contrast agent, delay to contrast infusion, contrast volume and
rate of infusion, reformatting technique and image format; and
(2) MRA: manufacturer and model, magnet strength, sequences,
contrast agent and rate of infusion, slice thickness, matrix, field
of view, and coverage. We also recorded the number of
indeterminate scans and the number and types of adverse events.
6. Reference standard parameters for IADSA: manufacturer
and model, the arterial territories imaged (unilateral or bilateral
internal carotids, unilateral or bilateral external carotids, and
unilateral or bilateral vertebral arteries), number of projections
(views) per artery, use of three-dimensional angiography, frame
rate, and matrix. We recorded the number of indeterminate
results and the number and types of adverse events.
We contacted the authors of studies that might have been subject
to differential verification bias because they had used more than
one reference standard. We requested the raw data in order to
recalculate the 2 x 2 contingency tables according to our defini-
tion of the target condition. We constructed the new contingency
tables using only IADSA as the reference standard. We therefore
excluded participants who underwent a reference standard other
than IADSA from the analysis.
There was likely to be inter-study variation in the positivity thresh-
old due to the fact that scans must be interpreted based on judge-
ment rather than on an explicit quantitative cut-point (Macaskill
2010). We therefore planned to organise the data according to
different thresholds if there were obvious discrepancies in the def-
inition of a positive test result. We planned to exclude uninter-
pretable scans from the contingency tables and evaluate them in a
sensitivity analysis if we encountered this issue.
Assessment of methodological quality
We assessed themethodological quality of each study using amod-
ified version of the QUADAS tool (Whiting 2003). QUADAS
appraises study quality by indicating the presence or absence of 14
key criteria through a series of questions that are answered as ’yes’,
’no’, or ’unclear’. The Cochrane Handbook for Systematic Reviews
of Diagnostic Test Accuracy advises omitting three items that relate
mainly to the quality of reporting rather than the quality of the
methodology.
In addition to the Cochrane recommended QUADAS questions,
we have added an extra criterion to evaluate whether those inter-
preting the index test were of an appropriate level of training that
we have defined as either an ’expert’ radiologist (a neuroradiolo-
gist) or an ’experienced’ radiologist (consultant level or equivalent
radiologist with five or more years of clinical practice).
This modified 12-item quality assessment form is available as
Appendix 3.
Two review authors (CBJ and RA-SS) independently assessed
study quality and a third review author (PMW) checked the index
test and reference standard attributes. Disagreements were medi-
ated through arbitration.
Statistical analysis and data synthesis
We calculated sensitivity and specificity, with 95% confidence in-
tervals (CI), for each index test in all studies. We used RevMan
5.2 to create coupled forest plots to visually evaluate the varia-
tion in the estimates of sensitivity and specificity between stud-
ies (RevMan 2012). We plotted the results in receiver operator
characteristic (ROC) space. Sensitivity was used to define the y-
axis, specificity defined the x-axis, and each point on the plot rep-
resents the proportion of true positives amongst those with our
defined target conditions against the proportion of false positives
amongst those lacking our defined target conditions for one par-
ticular study.
We planned to conduct a meta-analyses of study-specific pairs of
sensitivity and specificity to calculate pooled estimates of sensitiv-
ity and specificity using the bivariate method (Macaskill 2010).
6Computed tomography angiography or magnetic resonance angiography for detection of intracranial vascular malformations in patients
with intracerebral haemorrhage (Review)
Copyright © 2014 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
We performed the analyses using RevMan 5.2 (RevMan 2012)
and obtained pooled estimates using the Metandi package within
the Stata Statistical Software version 12.1 (StataCorp 2011).
Investigations of heterogeneity
Weplanned to address heterogeneity by adding covariates of inter-
est to the bivariate model. As described in the introduction, covari-
ates included equipment parameters for CTA, MRA, and IADSA,
the experience of those reading the index test and reference stan-
dard, the timing of the index test with respect to symptom onset,
the average participant age, and the average haematoma size.
Sensitivity analyses
We planned sensitivity analyses to evaluate the robustness of our
eligibility criteria by exploring the effect of including only adults
(as opposed to all age groups) on the pooled sensitivity and speci-
ficity results. We also planned to undertake sensitivity analyses for
each of the 12 modified QUADAS criteria described in Appendix
3 to determine the effect of poor study quality on the overall re-
sults. If feasible, we intended to perform a sensitivity analysis on
the effect of excluding uninterpretable index test results by instead
re-classifying them as a negative result. We planned to perform
these analyses whenmore than three studies were available for each
strata.
Assessment of reporting bias
We contacted the authors of the studies that were excluded because
they did not report specific outcomemeasures of interest to inquire
whether these data were available but had not been published. If
data were available and met the inclusion criteria, we included
them in our analysis.
We planned to assess publication bias using the method described
by Deeks 2005 if there were a sufficient number of studies avail-
able.
R E S U L T S
Results of the search
The MEDLINE and EMBASE searches identified 4472 unique
citations. Of these, we considered 37 relevant to the purpose of
our review. We retrieved full-text articles and subsequently ex-
cluded 26 following review. We were unsure about whether two
articles could be included but ultimately excluded them since
the corresponding author did not reply to our requests for addi-
tional information (Sasiadek 2000; Sasiadek 2002). We excluded
the remaining articles because the index test was not computed
tomography angiography (CTA)/magnetic resonance angiogra-
phy (MRA) (n = 2) (Pott 1992; Kadkhodayan 2012), intra-arte-
rial digital subtraction angiography (IADSA) was not the refer-
ence standard (n = 8) (Awad 1992; Hünerbein 2003; Lee 2007;
Elhammady 2008; Sha 2008; Bekelis 2012; Wijman 2012; Kamel
2013), there was no comparison between CTA/MRA and IADSA
(n = 1) (Zheng 2012), the article was a review rather than orig-
inal research (n = 6) (Bowen 2007; Truwit 2007; Kidwell 2010;
Campeau 2012; Chandra 2012; Khosravani 2013), the overall
study size was smaller than 20 participants (n = 1) (Evans 2005),
or the study was not performed on patients presenting with ICH
(n = 6) (Fasulakis 2003; Dammert 2004; Griffiths 2006; Gross
2012; Leung 2012; Li 2013).
Eleven studies, each published as an individual report, compris-
ing a total of 927 participants, met our inclusion criteria (Figure
1). Eight studies compared CTA with IADSA (Eshwar Chandra
1998; Murai 1999; Delgado Almandoz 2009; Romero 2009;
Yeung 2009; Yoon 2009; Wong 2011; Ma 2012) and three stud-
ies compared MRA with IADSA (Wong 2010; Lummel 2012;
Zhou 2012). The details of included studies are described in the
Characteristics of included studies table.
7Computed tomography angiography or magnetic resonance angiography for detection of intracranial vascular malformations in patients
with intracerebral haemorrhage (Review)
Copyright © 2014 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Figure 1. Study flow diagram.
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Methodological quality of included studies
The quality of the 11 included studies varied considerably when
evaluated according to our modified QUADAS criteria (Figure
2). Five were prospective (all CTA studies, 354 participants), five
were retrospective (three CTA studies, 172 participants; twoMRA
studies, 218 participants), and the design of one study was un-
clear (MRA, 183 participants). All studies apart from one failed
to provide a formal definition of a positive scan apart from general
statements about identification of a vascular or ’secondary’ cause
for the ICH.
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Figure 2. Methodological quality summary: review authors’ judgements about each methodological quality
item for each included study.
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Representative spectrum
CTA
Eight studies comprising a total of 526 participants compared
CTA with IADSA. All studies described their inclusion crite-
ria. However, only two studies comprising a total of 133 partici-
pants (Figure 2) met our definition of a representative spectrum
(Appendix 3).
Sample size for all eight studies ranged from 31 to 210. The mean
or median age of participants in each study ranged from 28 to
56 years. Two studies included participants under 16 years of
age (Eshwar Chandra 1998; Romero 2009). Two studies did not
document mean or median participant age (Delgado Almandoz
2009; Ma 2012). The proportion of females ranged from 33% to
54%.Two studies did not document gender distribution (Delgado
Almandoz 2009; Ma 2012). One study reported the proportion
of participants with pre-existing hypertension at the time of ICH
(14%) (Romero 2009).No study indicated howmany participants
had experienced prior ICH.
Three studies documented the types of intracranial haemorrhage at
the time of presentation (Romero 2009; Yoon 2009;Wong 2011).
The proportion presenting with ’pure’ ICH ranged from 10%
to 56%. The proportion presenting with ICH and subarachnoid
haemorrhage (SAH) ranged from 9% to 39%, the proportion pre-
sentingwith ICHand intraventricular haemorrhage (IVH) ranged
from 10% to 34%, and the proportion presenting with ICH and a
subdural haematoma (SDH) ranged from 3% to 17%. Two stud-
ies (Romero 2009; Yoon 2009) contained participants who pre-
sented with ICH combined with both SAH and IVH (23% and
8% of participants respectively).One study contained participants
with ICH and simultaneous SAH, IVH, and SDH (5%) (Romero
2009). Five studies reported the location of the presenting ICH
(Eshwar Chandra 1998; Romero 2009; Yeung 2009; Yoon 2009;
Wong 2011). The presenting ICH was lobar in 56% to 100% of
cases, deep in 0% to 19% of cases, and infratentorial in 0% to
21% of cases. No study reported themean or median ICH volume
at presentation.
MRA
Three studies comprising a total of 401 participants compared
MRA with IADSA. The inclusion and exclusion criteria were
clearly described and the patient population met our definition
of a representative spectrum in two of three studies (Appendix 3).
The mean age ranged from 42 years (standard deviation (SD) 15)
to 53.4 years (range 14 to 82). The proportion of females ranged
from 34% to 54%. Participant withdrawals were explained but
there was no documentation about whether adverse events were
encountered. All participants could be accounted for in the stud-
ies. The proportion with pre-existing hypertension was 28% and
34% in the two studies that reported these data (Wong 2010;
Zhou 2012). It is unclear whether any of the participants had ex-
perienced prior ICH.
One study documented the types of intracranial haemorrhage at
the time of presentation (Wong 2010). Nineteen patients pre-
sented with ICH and concomitant IVH. The presenting ICH was
lobar in 53% of cases, deep in 32% of cases, and infratentorial
in 15% of cases. The mean or median ICH size at the time of
presentation was not reported.
Acceptable reference standard
CTA
We deemed the reference standard to be of unclear quality in four
studies (Eshwar Chandra 1998; Murai 1999; Delgado Almandoz
2009; Ma 2012), which did not document the equipment, tech-
nical specifications, and the level of expertise of those interpreting
the IADSA in sufficient detail. A neuroradiologist interpreted the
IADSA in five studies (Romero 2009; Yeung 2009; Yoon 2009;
Wong 2010; Ma 2012); the expertise of those interpreting the
IADSA was not documented in three studies (Eshwar Chandra
1998;Murai 1999; Delgado Almandoz 2009), and one study used
a combination of an expert neuroradiologist and a neurosurgeon
(Wong 2011).
MRA
We deemed the reference standard to be of unclear quality in one
study (Lummel 2012), which did not document the equipment,
technical specifications, and the level of expertise of those inter-
preting the IADSA in sufficient detail. A neuroradiologist inter-
preted the IADSA in two studies (Wong 2010; Lummel 2012),
while the level of expertise of those interpreting the IADSA was
not documented in the third study (Zhou 2012).
Acceptable delay between tests
CTA
Three studies documented time from ICH symptom onset to the
CTA (one study had a mean of six hours from symptom onset to
CTA (Murai 1999), one studied required that the CTA be per-
formed ≤ 24 hours from ICH onset (Delgado Almandoz 2009),
one study required the CTA to be performed ≤ 120 hours from
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ICH onset (Wong 2011)), and one study documented the time
from ICH symptom onset to IADSA (IADSA had to be com-
pleted≤ 144 hours from ICH onset (Wong 2011)). Three studies
reported on themean or median interval fromCTA to IADSA. All
IADSA examinations were performedwithin 48 hours of the CTA
in one study (Romero 2009), IADSA was performed a median of
two days from the CTA in one study (Yeung 2009), and there was
a mean of 16.1 hours (SD 9 hours) between the CTA and IADSA
in the third study (Yoon 2009).
MRA
The time from ICH symptom onset to both the index test and
reference standard ranged from six to 18 weeks in the one MRA
study that reported these values (Wong 2010).
Partial verification bias avoided
CTA
Three studies avoided partial verification bias by prospectively re-
cruiting patients with the intention that each participant would
undergo both CTA and IADSA (Yoon 2009; Wong 2011; Ma
2012). It was unclear whether the results of the CTA influenced
the selection of those undergoing IADSA in one study (Eshwar
Chandra 1998). The CTA result influenced the timing of IADSA
in one prospective study (Murai 1999), and certainly would have
influenced the decision to perform IADSA in the three retro-
spective studies (Delgado Almandoz 2009; Romero 2009; Yeung
2009).
MRA
Partial verification bias would be expected to be present in all three
retrospective studies (Wong 2010; Lummel 2012; Zhou 2012),
since the results of theMRAwould certainly influence the decision
to proceed to IADSA in routine clinical practice.
Differential verification bias
CTA
Three studies used a combination of IADSA and pathology or
operative findings as a reference standard (Eshwar Chandra 1998;
Delgado Almandoz 2009; Romero 2009).We contacted study au-
thors and extracted data related only to those participants under-
going both CTA and IADSA. This may have introduced a form of
selection bias as those undergoing pathological confirmation may
have had larger ICH volumes (leading to surgery or death) that
could have obscured the target condition on imaging. However,
it does remove the influence of differential verification bias. All
other studies used IADSA as the exclusive reference standard.
MRA
All studies restricted the reference standard to IADSA.
Incorporation bias
Incorporation bias was avoided in all 11 included studies.
Reference standard result blinded
CTA
Three of five prospective studies explicitly mention that IADSA
was interpreted blinded to the index result (Yoon 2009; Wong
2011;Ma 2012). Two neuroradiologists in one retrospective study
read the IADSA at least one month after the CTA (Yeung 2009).
However, while this would reduce the risk of recall bias, it would
not eliminate it altogether. One retrospective study reported that
the IADSA scans were reported with knowledge of theCTA results
(Romero 2009).
MRA
One retrospective study explicitly mentioned that IADSA was in-
terpreted blinded to the index result (Wong 2010). The blinding
status was unclear in one study (Zhou 2012) and the final study
involved interpretation of the IADSA with knowledge of the re-
sults of the MRA (Lummel 2012).
Index test result blinded
CTA
The index test was interpreted blinded to the results of the IADSA
in six studies (Delgado Almandoz 2009; Romero 2009; Yeung
2009; Yoon 2009; Wong 2011; Ma 2012), while no statement to
this effectwasmade in the remaining two studies (Eshwar Chandra
1998; Murai 1999).
MRA
The index test was interpreted blinded to the results of the IADSA
in two studies (Wong 2010; Lummel 2012), while no statement
to this effect was made in the remaining study (Zhou 2012).
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Relevant clinical information
CTA
Five studies required that the CTA and IADSA were inter-
preted blinded to the participant’s clinical information (Delgado
Almandoz 2009; Romero 2009; Yeung 2009; Wong 2011; Ma
2012), while the three remaining studies did not address this point
(Eshwar Chandra 1998; Murai 1999; Yoon 2009).
MRA
Two studies required that the MRA and IADSA were interpreted
blinded to the participant’s clinical information (Wong 2010;
Lummel 2012), while the one remaining study did not address
this point (Zhou 2012).
Uninterpretable results reported
No study documented whether uninterpretable images were en-
countered.
Withdrawals explained
No study reported whether there were participants who had to
withdraw due to adverse events or due to an inability to toler-
ate the index test or reference standard. All participants could be
accounted for in each study but the process by which the final
study population was reached was unclear in three studies (Eshwar
Chandra 1998; Yeung 2009; Wong 2011).
Index tests interpreted by an expert
CTA
A neuroradiologist interpreted the CTA in six studies. CTA was
interpreted by either a neuroradiologist or neurosurgeon in one
study (Murai 1999) and the level of expertise of those interpreting
the dynaCT scan was not clear in one study (Eshwar Chandra
1998).
MRA
MRA images were interpreted by neuroradiologists or neurosur-
geons in two studies (Wong 2010; Zhou 2012) and were inter-
preted exclusively by neuroradiologists in the final study (Lummel
2012).
Findings
Studies on CTA
Figure 3 shows the paired forest plot for sensitivity and specificity
for CTA compared with IADSA. The pooled estimates of sensitiv-
ity and specificity were 0.95 (95%CI 0.90 to 0.97) and 0.99 (95%
CI 0.95 to 1.00) respectively (Figure 4). Approximately 85% of
the estimates of specificity were close to or at the ’ceiling level’
(specificity of 1.00). The pooled positive likelihood ratio was 73
(95% CI 19 to 277) and the negative likelihood ratio was 0.06
(95% CI 0.03 to 0.10).
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Figure 3. Forest plot of the paired sensitivity and specificity values for the detection of an intracranial
vascular malformation following intracerebral haemorrhage using computed tomography angiography (CTA)
or magnetic resonance angiography (MRA) compared to a reference standard of catheter intra-arterial digital
subtraction angiography.
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Figure 4. Pooled estimates of sensitivity and specificity for computed tomography angiography (black) and
magnetic resonance angiography (red) plotted in receiver operator characteristic space of studies compared
with catheter intra-arterial digital subtraction angiography for the detection of intracranial vascular
malformations following intracerebral haemorrhage.
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The results remained robust in a sensitivity analysis in which six
studies that recruited only adult patients, comprising 465 partici-
pants, were evaluated separately (Murai 1999; Delgado Almandoz
2009; Yeung 2009; Yoon 2009; Wong 2011; Ma 2012). The
pooled estimates of sensitivity and specificity were 0.95 (95% CI
0.89 to 0.98) and 0.99 (95% CI 0.95 to 1.00).
We performed sensitivity analyses when more than three studies
for each analysis were available. The results remained robust in
the following pre-specified sensitivity analyses where only those
meeting each study criterion were analysed.
• Acceptable reference standard (four studies, 251
participants): sensitivity 0.99 (95% CI 0.79 to 1.00) and
specificity 0.98 (95% CI 0.88 to 1.00).
• Delay between tests reported (four studies, 251
participants): sensitivity 0.99 (95% CI 0.79 to 1.00) and
specificity 0.98 (95% CI 0.88 to 1.00).
• Partial verification bias avoided (four studies, 323
participants): sensitivity 0.94 (95% CI 0.90 to 0.97) and
specificity 0.99 (95% CI 0.96 to 1.00).
• Index test results blinded (six studies, 451 participants):
sensitivity 0.96 (95% CI 0.90 to 0.99) and specificity 0.99 (95%
CI 0.94 to 1.00).
• Index test interpreted by an expert (seven studies, 482
participants): sensitivity 0.96 (95% CI 0.90 to 0.98) and
specificity 0.99 (95% CI 0.95 to 1.00).
We were unable to perform sensitivity analyses for differential ver-
ification bias (all studies met the criterion), incorporation bias (all
studies met the criterion), relevant clinical information provided
to those interpreting the test (no study met this criterion), report-
ing and reclassifying uninterpretable images as negative (no study
met this criterion), and explanation of study withdrawals (all stud-
ies met this criterion).
Although there were sufficient data available (more than 85%
complete for all studies) to address heterogeneity between stud-
ies according to gender, mean or median age, equipment parame-
ters, and experience of those interpreting the CTA, the shortage of
available studies (n = 8) precluded formal analysis of heterogene-
ity. However, there was no indication of heterogeneity based on
visual inspection of the forest and ROC plots and the low variance
estimates. There were insufficient data to assess heterogeneity ac-
cording to the equipment parameters of IADSA, the experience
of those interpreting the IADSA studies, the timing of the CTA
with respect to symptom onset, and average haematoma size.
No studies reported adverse events.
We did not formally evaluate publication bias due to the limited
number of studies (Deeks 2005).
Studies on MRA
Figure 3 shows the paired forest plot for sensitivity and specificity
for MRA compared with IADSA. The pooled estimates of sensi-
tivity were 0.98 (95% CI 0.80 to 1.00) and for specificity were
0.99 (95% CI 0.97 to 1.00) for the three studies (Figure 4). The
corresponding positive likelihood ratio was 91 (95% CI 22 to
376) and the negative likelihood ratio was 0.02 (95% CI 0.002 to
0.234).
We could not perform our pre-specified sensitivity analyses due to
the limited number of studies.
No studies reported adverse events.
We did not formally evaluate publication bias due to the limited
number of studies (Deeks 2005).
Comparison of CTA and MRA
Using all included studies, we compared the diagnostic accuracy
of CTA and MRA by adding covariate terms for test type to the
parameters of the bivariate model to determine the effect of test
type on sensitivity and specificity. We used a likelihood ratio test
to assess the statistical significance of the difference in sensitiv-
ity and specificity between tests by comparing models with and
without the covariate terms in the bivariate model. The likelihood
ratio test indicated no evidence (P value = 0.6) of a difference in
sensitivity or specificity, or both between CTA and MRA (Figure
4; Summary of findings). Indirect comparisons can be prone to
confounding, however, and direct comparisons between CTA and
MRA are currently lacking.
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Summary of findings
Population Individuals with acute intracerebral haemorrhage (with or without extension into other intracranial spaces) who are well enough to undergo computed
tomography angiography (CTA) or magnetic resonance angiography (MRA) and catheter intra-arterial digital subtraction angiography (IADSA), and have no
contraindications to either test
Setting Ideally, the intended setting is a population-based representation of all patients with intracerebral haemorrhage. However, the included studies were all
restricted to secondary and tertiary care from Asia (5 CTA, 2 MRA), North America (3 CTA), and Europe (1 MRA)
Index test CTA or MRA
Reference standard Catheter IADSA
Number of studies 8 cross-sectional studies that evaluated CTA and IADSA in the same patient population and 3 cross-sectional studies that evaluated MRA and IADSA in the
same patient population
Test Studies Cases Total Summary sensitivity (95% CI) Summary specificity (95% CI)
CTA 8 180 526 0.95 (0.90 to 0.97) 0.99 (0.95 to 1.00)
MRA 3 122 401 0.98 (0.80 to 1.00) 0.99 (0.97 to 1.00)
Comparison of CTA and MRA In studies of variable methods and degrees of bias, the diagnostic accuracy of both CTA and MRA appear comparable to IADSA for detection of intracranial
vascular malformations following intracerebral haemorrhage. There was no evidence to suggest a difference in sensitivity or specificity, or both, between CTA
and MRA (P value = 0.6). However, there was no study that directly compared the accuracy of CTA and MRA
CAUTION: The results on this table should not be interpreted in isolation from the results of the individual included studies contributing to each summary test accuracy measure. These are
reported in the main body of the text of the review
CI: confidence interval
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D I S C U S S I O N
This systematic review and meta-analysis identified eight studies
comparing the diagnostic accuracy of computed tomography an-
giography (CTA) with intra-arterial digital subtraction angiogra-
phy (IADSA) and three studies comparing magnetic resonance
angiography (MRA) with IADSA. The pooled estimates of sen-
sitivity and specificity were 0.95 (95% confidence interval (CI)
0.90 to 0.97) and 0.99 (95% CI 0.95 to 1.00) respectively for
CTA and 0.98 (95% CI 0.89 to 1.00) and 0.99 (95% CI 0.98 to
1.00) respectively forMRA. Studies were of variable methodologi-
cal quality with discrepant inclusion criteria, retrospective designs,
and high rates of partial verification bias.
Summary of main results
The Summary of findings summarises our findings for the eight
included studies comparing CTA with IADSA and the three stud-
ies comparing MRA with IADSA. CTA and MRA appear equiv-
alent to IADSA for the detection of intracranial vascular malfor-
mations following intracerebral haemorrhage (ICH). However, it
is important to consider that sample sizes were typically small and
study designs varied. High rates of partial verification bias (50%)
complicate evaluation of sensitivity. Inflated estimates of sensitiv-
ity would be expected in situations where the index test is used to
select participants for the reference standard. Furthermore, differ-
ential verification bias had complicated studies that used IADSA,
pathology, or a combination of pathology and IADSA as a refer-
ence standard; we mitigated this effect by restricting our analyses
to participants in whom IADSA had been the reference standard.
The majority of included studies were ’streamlined’ to select a
patient population with the greatest likelihood of harbouring an
underlying vascular malformation or aneurysm. Focused exclu-
sion of patients with alternative diagnoses can falsely elevate speci-
ficity since disease mimics are preferentially excluded. Studies ex-
cluding patients with pre-existing hypertension or deep haemor-
rhages, a population of patients with a lower yield of aneurysms
and arteriovenous malformations on IADSA performed follow-
ing ICH (Cordonnier 2010), would be particularly prone to this
phenomenon. In addition, broad selection criteria are required as
certain subgroups of patients, such as those older than 50, have
been found to have an appreciable yield of vascular malformations
and aneurysms on IADSA following ICH despite a common per-
ception to the contrary (Cordonnier 2010).
The timing of theCTA,MRA, and IADSA, both in respect to each
other and from the onset of symptoms, would also be expected
to exert a major influence on overall estimates of diagnostic accu-
racy. The haemorrhage could obscure the vascular malformation
or aneurysm if the scan is performed too early. Almost half of the
studies did not report time from symptom onset to CTA, only one
study recorded the time from symptom onset to IADSA, and less
than half reported the delay between CTA and IADSA. Likewise,
although all three MRA studies reported time from symptom on-
set to index test, none of them reported the delay between the
MRA and IADSA. The optimal timing of scans has not been es-
tablished but reporting duration and correlating it with accuracy
is a crucial step to resolving this uncertainty.
Strengths and weaknesses of the review
Weused a comprehensive search strategy on eight major electronic
databases without any restrictions on date, language, or country of
origin. We identified studies both with and without a diagnostic
test accuracy filter incorporated into the search strategy.
We minimised patient overlap by only selecting the most recent
study published where there were many from the same patient
cohort. Two review authors evaluated selected full studies for in-
clusion and a combination of two of three review authors (CBJ
and PMW or RA-SS) with complementary expertise (two neurol-
ogists and one neuroradiologist) independently extracted data and
assessed study quality.
The main limitations pertain to the dearth of studies and quality
of the evidence. We identified few studies, methodological quality
was variable, sample sizes were small, and there was incomplete
reporting of patient and test characteristics.
These issues are common in studies of diagnostic test accuracy and
tend to lead to overestimation of diagnostic performance, espe-
cially when performed using a narrow spectrumof patients (Lijmer
1999; Rutjes 2006). Adherence to the Standards for Reporting of
Diagnostic Accuracy (STARD) guidelines will facilitate optimal
design and reporting of future studies (Bossuyt 2003).
We did not identify any comparative test accuracy studies (i.e.
studies that compared CTA with MRA using IADSA as the refer-
ence standard). Due to limited studies and minimal heterogeneity
we were not able to perform in-depth sensitivity analyses evalu-
ating the contribution of study quality to the overall estimates of
sensitivity and specificity. Similarly, we could not evaluate all pre-
specified features of interest for heterogeneity due to inconsistent
reporting. We also could not investigate heterogeneity and publi-
cation bias due to insufficient studies and small sample sizes.
We were unable to evaluate practicality and applicability formally
due to a lack of information on patient tolerability, the frequency
with which uninterpretable scans were encountered, the conse-
quences of false negative diagnoses, andmeasures of cost-effective-
ness.
Applicability of findings to the review question
Both CTA and MRA appear comparable to IADSA for the detec-
tion of intracranial vascular malformations following ICH. How-
ever, routine use of CTA and MRA will need to take into account
practicality and cost-effectiveness. CTA is quicker and less invasive
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than IADSA. Patient tolerability is therefore improved, making it
a more practical option for critically ill patients. It is also more
widely available and more easily accessible that IADSA. Likewise,
MRA is also less invasive and, though not as appropriate for crit-
ically ill patients, its adverse event profile compares favourably
to CTA since it does not require radiation. Although less avail-
able than CTA, it is at least as accessible as IADSA. IADSA is a
more demanding procedure requiring operators with highly spe-
cialised training in interventional techniques. However, although
CTA and MRA are relatively low-risk procedures, they can cause
contrast reactions and the overall risk of adverse events has yet to
be formally compared with IADSA. For instance, in certain cir-
cumstances, patient radiation exposure may be greater with CTA
compared with IADSA (Manninen 2012).
The consequences of a false negative diagnosis have yet to be evalu-
ated. A missed intracranial vascular malformation may predispose
the patient to recurrent ICH or may simply necessitate IADSA,
which potentially negates the value of CTA or MRA as first-line
imagingmodalities.Neuroradiologists in the included studieswere
routinely denied access to basic clinical information, creating an
artificial situation that is not representative of routine clinical prac-
tice. A practical benefit to IADSA is that, unlike CTA and MRA,
images can be reviewed in ’real time’ and adjustments can therefore
be made to enhance image quality prior to the completion of the
test. A cost-effectiveness analysis comparing CTA or MRA with
IADSA is lacking.
Although there appeared to be very little heterogeneity between
studies according to CTA equipment parameters, it is possible
that the accuracy of CTA compared with IADSA may further
improve with advancing technology. The two earliest studies were
performed using single-slice CT scanners that are now obsolete
in high-income countries (Eshwar Chandra 1998; Murai 1999).
The expectation therefore will be that the summary estimate of the
diagnostic accuracy of CTA will continue to compare favourably
with IADSA asmore evidence accrues from studies benefiting from
increasingly advanced technology.
A U T H O R S ’ C O N C L U S I O N S
Implications for practice
In conclusion, we evaluated eight studies that compared computed
tomography angiography (CTA) with intra-arterial digital sub-
traction angiography (IADSA) and three studies that compared
magnetic resonance angiography (MRA) with IADSA for the de-
tection of intracranial vascular malformations following intracere-
bral haemorrhage (ICH). Studies were of variable methodological
quality. Our results suggest that CTA and MRA are probably of a
comparable diagnostic accuracy to IADSA in patients with ICH.
However, these estimates should be interpreted with caution be-
cause they are based on a few studies, of variable methodological
quality, with small sample sizes. Neither practicality nor cost-ef-
fectiveness was evaluated in the included studies. Additional, well-
designed studies are needed to confirm whether CTA orMRA can
be used as the primary imaging modality for diagnosing intracra-
nial vascular malformations following ICH.
Implications for research
Future research should focus on the diagnostic performance of
CTA and MRA in a broad spectrum of patients following ICH.
These studies should also investigate the diagnostic test accuracy of
technical advances in MRA, such as high-resolution, contrast-en-
hanced and time-resolved techniques (Hadizadeh 2008; Taschner
2008), and in CTA, such as 4D-CTA using 320 detector row
computed tomography (CT) scanners (Willems 2011; Willems
2012). Additional analyses will be required to evaluate the cost-
effectiveness of these tests, and their impact on patients’ overall
outcome. We were unable to perform a direct comparison of CTA
and MRA (using IADSA as the reference standard) due to limited
data, but future studies should address this issue.
Future studies should focus on the implications of false negative
and false positive results. These two relative misclassification costs
are rarely equal (Mallett 2012). A false negative CTA or MRA re-
sult leaves the patient at risk of recurrent haemorrhage if IADSA is
not performed. Alternatively, a false positive will usually not result
in harm from inappropriate treatment (surgery, radiosurgery, or
embolisation) because IADSA is usually done before any proce-
dure. Under these circumstances, a higher sensitivity at the relative
expense of specificity may be optimal.
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C H A R A C T E R I S T I C S O F S T U D I E S
Characteristics of included studies [ordered by study ID]
Delgado Almandoz 2009
Clinical features and settings The study enrolled consecutive patients ≥ 18 years of age presenting to a tertiary care
emergency centre in Boston, USA, from 1 January 2000 to 1 November 2008, with evi-
dence of intraparenchymal haemorrhage on CT. Patients had to be evaluated with CTA
within 24 hours of presentation. Patients with associated subarachnoid haemorrhage in
the basal cisterns, loss of grey-white matter differentiation in a vascular territory suggest-
ing a pre-established acute ischaemic stroke, a known intracranial vascular malformation
or mass lesion, or known probable cerebral amyloid angiopathy according to Boston
criteria were excluded
Participants 775 patients were screened of which 210 were eligible and enrolled.Mean participant age
was not documented. The gender breakdown was not provided. No details were available
about co-morbidities. No details were provided about ICH location or extension of
blood into other intracranial compartments
Study design Retrospective study of consecutive patients
Target condition and reference standard(s) The reference standards were IADSA and intraoperative and pathological findings. Data
exclusive to IADSA were obtained. IADSA equipment and technical specifications were
not documented. A positive result was a vascular abnormality accounting for the haem-
orrhage
Index and comparator tests The index test was CTA performed using a 16- or 64-slice LightSpeed GE Healthcare
helical CT scanner. The base of the C1 vertebrae to the vertex was scanned using a pitch
of 0.5, 1.25 mm slice thickness, and a field of view of 22 cm. Non-ionic contrast material
(65 to 85 mL) was administered by power injector at 4 to 5 mL/s with either a fixed
25-second delay between onset of contrast material injection and start of scanning (or a
delay of 40 seconds if the participant had atrial fibrillation) or by SmartPrep automatic
contrast-bolus triggering technique. A positive result was defined as any underlying
vascular abnormality accounting for the haemorrhage
Follow-up The study authors did not state whether there were any study withdrawals. The authors
did not report whether there were any instances of uninterpretable images. The authors
did not report whether any participants suffered an adverse event
Level of expertise of those interpreting the
index test
The CTA source and maximum intensity projection images were reviewed by 2 neuro-
radiologists blinded to the participant’s clinical information
Notes The resulting 1.25 mm thick axial CTA source images were digitally archived and stan-
dard maximum intensity projection images of the major intracranial vessels were created
by the 3-D laboratory
Table of Methodological Quality
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Delgado Almandoz 2009 (Continued)
Item Authors’ judgement Description
Representative spectrum? No Patients had to be evaluated with CTA
within 24 hours of presentation to be eligi-
ble for the study
Acceptable reference standard?
All tests
Unclear The reference standardwas IADSA andwas
described in sufficient detail to replicate.
However, the level of expertise of those in-
terpreting the images was not documented
Acceptable delay between tests?
All tests
No The authors did not report the delay be-
tween the CTA and IADSA
Partial verification avoided?
All tests
No This is a retrospective study and, in routine
practice, the CTA result would influence
the decision to proceed to either to IADSA
or straight to surgery
Differential verification avoided?
All tests
Yes IADSA, surgical findings, and pathology
were used as reference standards. However,
data exclusive to IADSA as a reference stan-
dard were obtained from the authors
Incorporation avoided?
All tests
Yes CTA did not form a part of the reference
standard
Reference standard results blinded?
All tests
Unclear The reference standard was the IADSA fi-
nal report. It is not clear whether those in-
terpreting the IADSA images were privy to
results of the CTA scans
Index test results blinded?
All tests
Yes Those interpreting the CTA were blinded
to the IADSA result
Relevant clinical information?
All tests
No Those interpreting the CTA images were
blinded to all relevant clinical information
including the participant’s clinical condi-
tion and other imaging reports
Uninterpretable results reported?
All tests
Unclear No comment was made about uninter-
pretable scans
Withdrawals explained?
All tests
Yes All participants could be accounted for in
the paper
Index test interpreted by an expert?
All tests
Yes The CTA source and MIP images were re-
viewed by two neuroradiologists
25Computed tomography angiography or magnetic resonance angiography for detection of intracranial vascular malformations in patients
with intracerebral haemorrhage (Review)
Copyright © 2014 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Eshwar Chandra 1998
Clinical features and settings This study enrolled patients from a tertiary care referral centre inChandigarh, India, with
acute, spontaneous ICH over a 5-year period from 1990 to 1995. Hypertensive patients
with haemorrhage in the thalamus, putamen, internal capsule, and the cerebellum were
excluded
Participants It is unclear how many patients were screened for inclusion or were potentially eligible
for enrolment. 45 participants were enrolled. Females comprised 36% (16/45) of the
total population. Mean or median age was not documented; age range was 3 to 75 years
old. It is unclear how many had a prior intracranial haemorrhage. ICH was lobar in 38
(84%) cases, deep in 4 (9%) cases, and infratentorial in 3 (7%) cases. Mean ICH size at
presentation was not documented
Study design Prospective case series. All participants underwent dynamic CT (CTA) and 44 of 45
underwent IADSA
Target condition and reference standard(s) The reference standards were IADSA and surgical findings. IADSA equipment and
technical specificationswere not documented. A positive resultwas a vascular abnormality
accounting for the haemorrhage
Index and comparator tests The index test was a dynaCT. All were performed using either a Siemens Somatom
HiQ S Scanner or a Shimadzu SCT 2000T. These were single-slice, non-spiral scanners.
Technical specifications were not documented. The study covered the Circle of Willis
and the region of the haematoma. A positive result was a vascular abnormality accounting
for the haemorrhage
Follow-up Study withdrawals and exclusions were explained. There was no statement made about
uninterpretable images. There was no statement regarding whether any adverse effects
occurred
Level of expertise of those interpreting the
index test
The level of experience of those interpreting the dynaCT scans was not documented
Notes There was no description of post-processing reconstruction of angiographic images
Table of Methodological Quality
Item Authors’ judgement Description
Representative spectrum? No Hypertensive patients with haemorrhage in
the thalamus, putamen, internal capsule,
and cerebellum were excluded
Acceptable reference standard?
All tests
Unclear The technical specifications and the back-
ground of those interpreting the IADSA
was not documented. There was no de-
scription of the extent to which the arterial
territories that surrounded the haematoma
were evaluated
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Eshwar Chandra 1998 (Continued)
Acceptable delay between tests?
All tests
No The delay between tests was not reported
Partial verification avoided?
All tests
Yes CTA did not determine who got IADSA
Differential verification avoided?
All tests
Yes IADSA and histopathological findings
were used as reference standards. Data ex-
clusive to IADSA could be extracted
Incorporation avoided?
All tests
Yes dynaCTdidnot formapart of the reference
standard
Reference standard results blinded?
All tests
Unclear There was no statement about whether
those interpreting the IADSA images were
blinded to the results of the dynaCT test
Index test results blinded?
All tests
Unclear There was no statement about whether
those interpreting the dynaCT test were
blinded to the results of the IADSA
Relevant clinical information?
All tests
Unclear There was no statement about whether
those interpreting the IADSA and dyn-
aCT were provided with all relevant clin-
ical information apart from the results of
the competing test
Uninterpretable results reported?
All tests
Unclear There was no statement about whether un-
interpretable results were encountered
Withdrawals explained?
All tests
Yes All participants could be accounted for in
the paper
Index test interpreted by an expert?
All tests
Unclear The level of experience of those interpret-
ing the dynaCT scans was not documented
Lummel 2012
Clinical features and settings Patients with acute ICH identified from an electronic in-hospital database in Munich,
Germany, were included if they had MRI/A imaging within 20 days of symptom onset
and had MRI/A and IADSA image quality that was sufficient for evaluation. Patients
with traumatic ICH were excluded. However, in the majority of cases, MRA was only
performed if CTA was ’normal’, meaning that this is likely a dilute sample of patients
with vascular malformations
Participants 120 patients were screened, 67 were eligible, and all were enrolled. Mean age was 53.4
years (range 14 to 82 years of age). There were 23 (34%) females and 44 (66%) males.
No details were provided about co-morbidities. ICHwas associated with intraventricular
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haemorrhage in 8 cases and subarachnoid haemorrhage in 5 cases. Haemorrhage was
lobar in 36 cases, basal ganglial in 13 cases, and infratentorial in 18 cases
Study design Retrospective case series. All participants underwent both MRA and IADSA although it
appears that IADSA preceded MRA in all cases
Target condition and reference standard(s) The reference standard was IADSA. The equipment was not described other than stating
that a Biplanar Neurostar DSA system was used. The authors did not provide a formal
definition but stated that their aim was to identify vascular malformations and other
bleeding sources in ICH patients
Index and comparator tests The index test was MRA. All scans were performed using either a Magnetom Symphony
1.5T unit or a Sign HDxt 3T unit. Magnet strength was either 1.5 or 3 T. Depending
on the participant, sequences included T1, contrast-enhanced T1, T2, proton density,
FLAIR, T2*, andDWI. All 67 participants had time of flight imaging and 40 participants
had contrast-enhanced imaging. The study authors did not provide a formal definition
but stated that their aim was to identify vascular malformations and other bleeding
sources in ICH patients
Follow-up Study withdrawals and exclusions were explained. There was no statement made about
uninterpretable images. There was no statement regarding whether any adverse effects
occurred
Level of expertise of those interpreting the
index test
MRA images were evaluated independently by 2 neuroradiologists
Notes IADSA images were evaluated by the same 2 neuroradiologists. There was no description
of post-processing reconstruction of angiographic images. Interrater reliability for the
detection of an IADSA positive lesion was excellent (kappa = 0.93)
Table of Methodological Quality
Item Authors’ judgement Description
Representative spectrum? No All patients with non-traumatic ICH who
had an MRI performed within 20 days of
symptom onset. However, in the majority
of cases, MRA was only performed if CTA
was ’normal’, meaning that this is likely a
dilute sample of patients with vascular mal-
formations
Acceptable reference standard?
All tests
Unclear The technical specifications of the IADSA
were not documented. There was no de-
scription of the extent to which the arterial
territories that surrounded the haematoma
were evaluated
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Acceptable delay between tests?
All tests
No The delay between tests was not reported
Partial verification avoided?
All tests
No The study was retrospective and in routine
practice it would be expected that MRA
would influence the choice to proceed to
IADSA
Differential verification avoided?
All tests
Yes Every participant underwent IADSA as the
reference standard
Incorporation avoided?
All tests
Yes MRA did not form a part of the reference
standard
Reference standard results blinded?
All tests
No The same 2 neuroradiologists interpreted
the IADSA images in the presence of
all participant information following their
analysis of MRA images
Index test results blinded?
All tests
Yes MRA was interpreted by 2 neuroradiolo-
gists blinded to all participant information
including IADSA results
Relevant clinical information?
All tests
No MRA was interpreted by 2 neuroradiolo-
gists blinded to all participant information
Uninterpretable results reported?
All tests
Unclear There was no statement about whether un-
interpretable results were encountered
Withdrawals explained?
All tests
Yes All participants could be accounted for in
the paper
Index test interpreted by an expert?
All tests
Yes MRA was interpreted by 2 neuroradiolo-
gists
Ma 2012
Clinical features and settings Patients with acute ICH admitted to West China Hospital in Sichuan, China, were
included if they were non-hypertensive (defined by medical history or clinical evidence
of normal blood pressure) and were between the ages of 18 and 45 years. Patients with
a traumatic ICH or primarily subarachnoid haemorrhage were excluded
Participants 436 patients were screened, 97 were eligible, and 92 were enrolled. 5 eligible patients
were excluded because of renal failure (n = 1) or a brain tumour (n = 4). Data regarding
age and gender were not provided. No details were provided about co-morbidities. No
details were provided about ICH location or extension of blood into other intracranial
compartments
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Study design Prospective case series. All participants underwent both CTA and IADSA
Target condition and reference standard(s) The reference standard was IADSA. The equipment was not described other than stating
a GE LCV + Advantx system was used. A positive test result was defined as a ’vascular
lesion’
Index and comparator tests The index test was CTA. All scans were performed using a GE LightSpeed VCT 64
scanner. The study covered ’rostral from C-2’. The parameters used included 0.625 mm
slice thickness every 0.6 mm and a pitch of 513:1. A total of 125 mL of Omnipaque
300 was administered intravenously at a rate of 4.0 to 5.0 mL/s using a 15-second prep
delay. A positive test result was defined as a ’vascular lesion’
Follow-up Study withdrawals and exclusions were explained. There was no statement made about
uninterpretable images. There was no statement regarding whether any adverse effects
occurred
Level of expertise of those interpreting the
index test
CTA images were evaluated independently by 2 neuroradiologists
Notes There was no description of post-processing reconstruction of angiographic images.
IADSA images were interpreted by 2 endovascular neuroradiologists
Table of Methodological Quality
Item Authors’ judgement Description
Representative spectrum? No Patients over the age of 45 and those with
pre-existing hypertension were excluded
Acceptable reference standard?
All tests
Unclear The technical specifications of the IADSA
were not documented. There was no de-
scription of the extent to which the arterial
territories that surrounded the haematoma
were evaluated
Acceptable delay between tests?
All tests
No The delay between tests was not reported
Partial verification avoided?
All tests
Yes CTA did not determine who underwent
IADSA
Differential verification avoided?
All tests
Yes Every participant underwent IADSA as the
reference standard
Incorporation avoided?
All tests
Yes CTA did not form a part of the reference
standard
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Reference standard results blinded?
All tests
Yes IADSA was reviewed by 2 endovascular
neuroradiologists blinded to clinical and
CTA data
Index test results blinded?
All tests
Yes CTA was reviewed by 2 neuroradiologists
blinded to clinical information
Relevant clinical information?
All tests
No IADSA and CTA were read blinded to all
clinical data
Uninterpretable results reported?
All tests
Unclear There was no statement about whether un-
interpretable results were encountered
Withdrawals explained?
All tests
Yes All participants could be accounted for in
the paper
Index test interpreted by an expert?
All tests
Yes CTA was interpreted by 2 neuroradiolo-
gists
Murai 1999
Clinical features and settings Patients referred to a tertiary care referral centre in Tokyo, Japan, for investigation of
spontaneous ICH. Patients were included if they had an initial CT scan performed
within 12 hours of symptom onset and a second CTwithin 24 hours of onset, a 3D-CTA
performed within 12 hours of symptom onset, and IADSA performed in the ’chronic
stage’. Patients who were clinically unstable or who had a history of chronic renal failure
or an allergic reaction to iodine were excluded
Participants 92 patients were screened, and 31 were eligible and enrolled. The mean age was 56 years
(range 34 to 74). Over half (17/31; 55%) were male. No details were provided about
co-morbidities. No details were provided about ICH location or extension of blood into
other intracranial compartments
Study design Prospective case series. All participants underwent both the index and reference standard
Target condition and reference standard(s) The reference standard was IADSA. The equipment used to perform IADSA was not
described. 1- or 2-vessel angiography was performed using cut-film technique. A positive
test result was the presence of a vascular abnormality as the cause of haemorrhage
Index and comparator tests The index test was CTA. All scans were performed using a Hitachi W 3000 AD he-
lical single-slice scanner. The study covered the Circle of Willis and the region of the
haematoma. The parameters used included 1 mm slice thickness, a 512 x 512 matrix, a
pitch of 1, and a 21 cm field of view. Participants were scanned from the posterior margin
of the haematoma through superior margin including the middle cerebral artery and
Circle of Willis. A total of 100 mL of Iomeprol (350 mg iodine/mL) was administered
intravenously at 2 mL/s using a 25-second pre-scanning delay. A positive result was the
identification of a vascular abnormality as the cause of haemorrhage
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Follow-up Study withdrawals and exclusions were explained. There was no statement made about
uninterpretable images. There was no statement regarding whether any adverse effects
occurred
Level of expertise of those interpreting the
index test
CTA images were evaluated by a neuroradiologist
Notes CTA images were reconstructed into 3 dimensions using a volume-rendered technique
through ’standard scanner software’. We were able to reclassify cases of moya-moya as
’negatives’ after receiving data from the study authors
Table of Methodological Quality
Item Authors’ judgement Description
Representative spectrum? No The study populationwas restricted to only
those patients undergoingCT scans at both
12 and 24 hours following symptom onset
and a CTA within 12 hours of symptom
onset
Acceptable reference standard?
All tests
Unclear The reference standardwas IADSA andwas
described in sufficient detail to replicate.
However, the level of expertise of those in-
terpreting the images was not documented
Acceptable delay between tests?
All tests
No The authors did not indicate the delay be-
tween the CTA and IADSA
Partial verification avoided?
All tests
No The CTA result determined when the par-
ticipant underwent IADSA
Differential verification avoided?
All tests
Yes All participants underwent both aCTAand
an IADSA
Incorporation avoided?
All tests
Yes CTA did not form a part of the reference
standard
Reference standard results blinded?
All tests
Unclear The authors did not state whether the
IADSA images were interpreted blinded to
the CTA result
Index test results blinded?
All tests
Unclear The authors did not state whether the
CTA images were interpreted blinded to
the IADSA result
Relevant clinical information?
All tests
Unclear The authors did not state whether all rou-
tine clinical information apart from the re-
sult of the competing test was available to
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those interpreting theCTAand IADSA im-
ages
Uninterpretable results reported?
All tests
Unclear The authors did not state whether uninter-
pretable images were encountered
Withdrawals explained?
All tests
Yes The authors explained study exclusions. All
enrolled participants were accounted for in
the analysis
Index test interpreted by an expert?
All tests
Yes A neuroradiologist reviewed all CTA im-
ages
Romero 2009
Clinical features and settings This study enrolled patients from a tertiary care referral centre in Boston, USA, with
acute, spontaneous ICH who underwent CTA over a 5-year period from 2002 to 2007.
Patients with known vascular anomalies, known brain neoplasms, those with imaging
findings suggestive of ischaemic stroke on admission, or those with subarachnoid haem-
orrhage within the Sylvian fissures or basal cisterns, or both, were excluded
Participants 80 patients were screened for inclusion. 43 patients were eligible and all were enrolled.
There were no study withdrawals. Females comprised 54% (23/43) of the total popula-
tion. The mean age was 28 years (range 4 to 40). 14% (6/43) of patients had pre-existing
hypertension. It is unclear howmany had a prior intracranial haemorrhage. 35% (15/43)
had pure ICH, 9% (4/43) had ICH with subarachnoid haemorrhage, 21% (9/43) had
ICH with intraventricular haemorrhage, 7% (3/43) had ICH with subdural haemor-
rhage, 23% (10/43) had ICH with subarachnoid and intraventricular haemorrhage, and
5% (2/43) had ICH with subarachnoid, intraventricular, and subdural haemorrhage.
ICH was lobar in 27 (63%) cases, deep in 5 (12%) cases, infratentorial in 9 (21%) cases,
and mixed in 2 (4%) cases. Mean ICH size at presentation was not documented
Study design Retrospective case series. All participants underwent both the index and reference stan-
dard
Target condition and reference standard(s) The reference standard was IADSA and surgical and pathological findings. Data exclu-
sive to IADSA were obtained. IADSA equipment and technical specifications were not
documented but was there were appropriate references to the literature that would enable
replication of the procedure. A positive result was a vascular abnormality accounting for
the haemorrhage
Index and comparator tests The index test was CTA performed using a 16- or 64-slice GE Healthcare helical CT
scanner. The skull base to the vertex was scanned using a pitch of 0.7, 3 mm slice
thickness, and a field of view of 18 cm. Isovue 370 non-ionic contrast material (90 to
120 mL) was administered by power injector at 2 to 3 mL/s with either a fixed 25-second
delay between onset of contrast material injection and start of scanning (or a delay of
40 seconds if the participant had atrial fibrillation) or by SmartPrep automatic contrast-
bolus triggering technique. A positive result was defined as any underlying vascular
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abnormality accounting for the haemorrhage
Follow-up The authors did not state whether there were any study withdrawals. The authors did
not report whether there were any instances of uninterpretable images. The authors did
not report whether any participants suffered an adverse event
Level of expertise of those interpreting the
index test
A neuroradiologist evaluated the CTA source and maximum intensity projection images
blinded to the participant’s clinical information
Notes The resulting 1.25 mm thick axial CTA source images were digitally archived and stan-
dard maximum intensity projection images of the major intracranial vessels were created
by the 3-D laboratory
Table of Methodological Quality
Item Authors’ judgement Description
Representative spectrum? No Patients older than 40 were excluded from
the study
Acceptable reference standard?
All tests
Yes IADSA was performed by an expert opera-
tor and was described well enough to repli-
cate through appropriate references to the
literature
Acceptable delay between tests?
All tests
Yes The time between IADSA and CTA was≤
48 hours
Partial verification avoided?
All tests
No This is a retrospective study and, in routine
practice, the CTA result would be expected
to influence the decision to proceed to ei-
ther to IADSA or straight to surgery
Differential verification avoided?
All tests
Yes IADSA, surgical findings, and pathology
were used as reference standards. However,
data exclusive to IADSA as a reference stan-
dard were obtained from the authors
Incorporation avoided?
All tests
Yes CTA did not form a part of the reference
standard
Reference standard results blinded?
All tests
No Those interpreting the IADSA knew the
results of the CTA scan
Index test results blinded?
All tests
Yes Those interpreting the CTA were blinded
to the IADSA result
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Relevant clinical information?
All tests
No Those interpreting the CTA images were
blinded to all relevant clinical information
including clinical condition and image re-
ports
Uninterpretable results reported?
All tests
Unclear No comment was made about uninter-
pretable scans
Withdrawals explained?
All tests
Yes All participants could be accounted for in
the paper
Index test interpreted by an expert?
All tests
Yes A neuroradiologist evaluated all CTA
source and MIP images
Wong 2010
Clinical features and settings This study enrolled patients from a tertiary care referral centre in Hong Kong, China,
who were admitted for cerebral angiography during the subacute phase (6 to 18 weeks)
following spontaneous ICH. All patients had ICH confirmed by CT scan performed
within 24 hours of clinical onset. Only patients whose ICH was detected with both
MRI and IADSA during the subacute phase were included in the study. Patients with
predominant subarachnoid haemorrhage were excluded as were those over 45 years with
pre-existing hypertension and thalamic, putaminal, or posterior fossa haemorrhage
Participants It is unclear how many patients were screened for inclusion. 169 patients were eligible
and all were enrolled. 18 participants had to withdraw from the study (10 were too
unwell to undergoMRI and 8 had anMRI from another institution). Females comprised
38% (57/151) of the total population. The mean age was 42 years (SD 15). Over one-
third of patients had pre-existing hypertension (52/151; 34%). It is unclear how many
had a prior intracranial haemorrhage. ICH was lobar in 80 (53%) cases, deep in 49
(32%) cases, and infratentorial in 22 (15%) cases. Mean ICH size at presentation was
not documented
Study design Retrospective case series. All participants underwent both the index and reference stan-
dard
Target condition and reference standard(s) The reference standard was a Phillips V3000 biplanar DSA unit with catheterisation
of the relevant cerebral vessels. Technical specifications were not documented. Relevant
cervical vessels were catheterised depending on the location of the ICH. Standard views
were obtained by hand injection of Omnipaque 300 6 mL to 9 mL and 3D angiography
was performed for participants with vascular lesions. A positive result was a vascular
abnormality accounting for the haemorrhage
Index and comparator tests The index test wasMRA performed using a 1.5 Tesla whole body scanner with a standard
head coil (Magnetom Sonata, Siemens Medical Systems or Intera-NT, Phillips Medical
Systems). MRA without contrast was performed using 3-dimensional time of flight with
a slice thickness of 0.7 mm. An arteriovenous malformation was suspected if the MRA
source images showed a conglomerate of parenchymal curvilinear structures. A dural
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arteriovenous fistula was suspected if MRA showed multiple curvilinear structures over
the surface of the brain without parenchymal evidence of a nidus
Follow-up Study withdrawals were explained by the authors. The authors did not report whether
there were any instances of uninterpretable images. The authors did not report whether
any participants suffered an adverse event
Level of expertise of those interpreting the
index test
All MRA images were reviewed by 2 neuroradiologists
Notes Standard maximum intensity projection images of the major intracranial vessels were
created following MRA
Table of Methodological Quality
Item Authors’ judgement Description
Representative spectrum? No Patients were admitted for IADSA dur-
ing the subacute period following ICH
onset. Patients over the age of 45 years
with pre-existing hypertension and thala-
mic, putaminal, or posterior fossa haemor-
rhages were excluded
Acceptable reference standard?
All tests
Yes IADSA was performed by an expert oper-
ator
Acceptable delay between tests?
All tests
Yes Time from onset to each test was recorded
Partial verification avoided?
All tests
No This is a retrospective study and, in routine
practice, the MRA result would influence
the decision to proceed to IADSA
Differential verification avoided?
All tests
Yes IADSA was the only reference standard
Incorporation avoided?
All tests
Yes MRA did not form a part of the reference
standard
Reference standard results blinded?
All tests
Yes Those interpreting the IADSA were
blinded to the MRA result
Index test results blinded?
All tests
Yes Those interpreting the MRA were blinded
to the IADSA result
Relevant clinical information?
All tests
Unclear It is unclear whether those interpreting the
MRA and IADSA images had access to all
relevant clinical information apart from the
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results of the competing scan
Uninterpretable results reported?
All tests
Unclear No comment was made about uninter-
pretable scans
Withdrawals explained?
All tests
Yes Participant withdrawals were explained
Index test interpreted by an expert?
All tests
Yes All MRA images were reviewed by 2 neu-
roradiologists
Wong 2011
Clinical features and settings The study enrolled consecutive patients from a tertiary care referral centre inHong Kong,
China, who presented with spontaneous, non-hypertensive and/or lobar intracerebral
haemorrhage within 96 hours of the clinical ictus. Patients older than 45 years with pre-
existing hypertension and thalamic, putaminal, or posterior fossa haemorrhage, those
older than 70 years, those with known renal impairment or an allergy to intravenous
contrast, and those with an emergency craniotomy before IADSA were excluded
Participants 966 patients were screened, 135 were eligible, and 109 consented to the study. Females
comprised 33% (36/109) of the total population. The mean age was 48 (SD 15). No
participants were considered to have had premorbid hypertension. It is unclear how
many had a prior intracranial haemorrhage. 12 participants (10%) had pure ICH, 18
(17%) had ICH with subdural haemorrhage, 42 (39%) had ICH with subarachnoid
haemorrhage, and 37 (34%) had ICHwith intraventricular haemorrhage. ICHwas lobar
in 80 (73%) cases, deep in 20 (19%) cases, and infratentorial in 9 (8%) cases. Mean
ICH size at presentation was 10 mL (SD 22)
Study design Prospective case series of consecutive patients presenting with spontaneous ICH
Target condition and reference standard(s) The reference standardwas aPhillipsV3000DSAunitwith catheterisation of the relevant
cerebral vessels. Technical specifications were not documented. Relevant cervical vessels
were catheterised depending on the location of the ICH. Standard views were obtained
by hand injection of Omnipaque 300 6 mL to 9 mL and 3D angiography was performed
for participants with vascular lesions. A positive result was defined as any underlying
vascular aetiology for the ICH
Index and comparator tests The index test was CTA performed using a 64-slice GE Healthcare helical CT scan with
the assistance of SmartPrep bolus tracking software. Arteriography was performed in
helical mode 120 kV, 220 mAs with no tilting. Axial images were reconstructed at 0.
625 mm intervals and stored as source images for further analysis with 3-dimensional
reconstruction. A positive result was defined as any underlying vascular aetiology for the
ICH
Follow-up The authors did not state whether there were any study withdrawals. The authors did
not report whether there were any instances of uninterpretable images. The authors did
not report whether any participants suffered an adverse event
37Computed tomography angiography or magnetic resonance angiography for detection of intracranial vascular malformations in patients
with intracerebral haemorrhage (Review)
Copyright © 2014 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Wong 2011 (Continued)
Level of expertise of those interpreting the
index test
2 neuroradiologists blind to both the clinical data and the catheter angiography findings
interpreted the CTA scans
Notes Standard multiplanar reformatting and maximum intensity projection images of the
major intracranial vessels were created following CTA. We were able to reclassify cases
of brain tumours and venous sinus thrombosis as ’negatives’ using the published data
Table of Methodological Quality
Item Authors’ judgement Description
Representative spectrum? No All patients 70 years of age or older and
those between 45 to 69 years of age with
pre-existing hypertension and thalamic,
putaminal, or posterior fossa haemorrhages
were excluded
Acceptable reference standard?
All tests
Yes IADSA was performed by an expert oper-
ator
Acceptable delay between tests?
All tests
Yes Time from onset to each test was recorded
Partial verification avoided?
All tests
Yes TheCTA result did not determine who un-
derwent IADSA
Differential verification avoided?
All tests
Yes IADSA was the only reference standard
Incorporation avoided?
All tests
Yes CTA did not form a part of the reference
standard
Reference standard results blinded?
All tests
Yes Those interpreting the IADSA were
blinded to the CTA result
Index test results blinded?
All tests
Yes Those interpreting the CTA were blinded
to the IADSA result
Relevant clinical information?
All tests
No Neuroradiologists interpreting the CTA
and IADSA scans were blinded to clinical
data
Uninterpretable results reported?
All tests
Unclear No comment was made about uninter-
pretable scans
Withdrawals explained?
All tests
Yes All participants could be accounted for in
the paper
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Index test interpreted by an expert?
All tests
Yes All CTA scans were interpreted separately
by 2 neuroradiologists
Yeung 2009
Clinical features and settings Patients admitted to tertiary care centre in Toronto, Canada, with nontraumatic, primar-
ily non-subarachnoid haemorrhage. Patients had to have undergone CTA and IADSA
prior to any surgical intervention
Participants 286 patients were screened and 55 met the eligibility criteria and were enrolled. The
study population was 58% (32/55) male and the median age was 49 years (range 16 to
71) for males and 50 years (range 30 to 79) for females. No details were provided about
co-morbidities. Lobar haemorrhages were present in 31 participants, deep haemorrhages
in 9, and infratentorial haemorrhages in 7. Pure intraventricular haemorrhage occurred
in 5 participants and pure subdural haemorrhage occurred in 3 participants
Study design Retrospective case series. All participants underwent both the index test and reference
standard
Target condition and reference standard(s) IADSAwas performed using a Phillips uniplane neuroangiographic unit. Technical spec-
ifications were not provided. Selective injections were performed according to the side
of the haematoma and the presence of a CTA detected abnormality. Both external and
internal carotid vessels were imaged in cases where no cause was seen on CTA. A positive
result was the presence of a ’secondary cause’ of haemorrhage
Index and comparator tests The index test was CTA. All scans were performed using a GE Medical Systems Light-
Speed Plus 4-slice CT or VCT 64-slice helical scanner. Each covered at least C2 to the
vertex. The parameters used included 1.25 or 0.625 mm slice thickness (depending on
the scanner). The matrix, pitch, and field of view were not specified. A total of 100 mL
to 125 mL Omnipaque 300 or Visipaque 320 were injected at a rate of 4.0 mL/s to 4.5
mL/s with either a 17-second delay or the use of Smart Prep at the pulmonary artery. A
positive result was the presence of a ’secondary cause’ of haemorrhage
Follow-up The authors did not state whether there were any study withdrawals. The authors did
not report whether there were any instances of uninterpretable images. The authors did
not report whether any participants suffered an adverse event
Level of expertise of those interpreting the
index test
3 staff neuroradiologists blinded to participant information and other imaging studies
independently reviewed all CTA studies
Notes Coronal and sagittal multiplanar reformatting images were recreated at 7 mm thickness
spaced by 3 mm. Bilateral 5-degree rotational multiplanar reformatting images were
created at the carotid terminus. The 3D rendered images were created on aGEAdvantage
Workstation
Table of Methodological Quality
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Item Authors’ judgement Description
Representative spectrum? Yes Participants all had acute intraparenchymal
ICH (with or without extension into other
intracranial spaces), were well enough to
undergo both tests, had no contraindica-
tions to either CTA or IADSA, and were
recruited with the express purpose of deter-
mining the diagnostic accuracy of CTA
Acceptable reference standard?
All tests
Yes The reference standardwas IADSA andwas
described in sufficient detail to replicate
Acceptable delay between tests?
All tests
Yes The delay between tests was reported
Partial verification avoided?
All tests
No The CTA result determined who under-
went IADSA
Differential verification avoided?
All tests
Yes IADSA was the only reference standard
Incorporation avoided?
All tests
Yes CTA did not form a part of the reference
standard
Reference standard results blinded?
All tests
Unclear 2 neuroradiologists reviewed the IADSAs
at least 1 month after the CTA to reduce
recall bias
Index test results blinded?
All tests
Yes The CTA images were interpreted blinded
to the IADSA result
Relevant clinical information?
All tests
No Those interpreting the CTA and IADSA
images were blinded to all participant in-
formation
Uninterpretable results reported?
All tests
Unclear The authors did not state whether uninter-
pretable images were encountered
Withdrawals explained?
All tests
Yes All participants could be accounted for in
the paper
Index test interpreted by an expert?
All tests
Yes 3 staff neuroradiologists independently re-
viewed all CTA studies
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Clinical features and settings The study included patients referred to a tertiary care referral centre in Seoul, South
Korea, for investigation of spontaneous ICH. Patients with predominant subarachnoid
haemorrhage, known pre-existing vascular abnormalities, or those with haemorrhage
into a tumour were excluded
Participants 105 patients were screened and 88 were eligible but 10 were not enrolled because they
deteriorated rapidly before both tests could be performed. A total of 78 participants
were therefore enrolled. The mean age was 48 years (SD 14). Over half (44/78; 56%)
were male. No details were provided about co-morbidities. All 78 had lobar ICH and
44% of patients (34/78) had extension of the bleed into the subarachnoid, subdural, or
intraventricular compartments
Study design Prospective case series. All participants underwent both the index and reference standard
Target condition and reference standard(s) IADSA was performed using a Phillips Integris system. A matrix of 1024 x 1024 pixels
was used. Bilateral selective internal carotid artery injections and either unilateral or
bilateral vertebral artery injections were performed for each case. Anteroposterior, lateral,
oblique, and additional views of each vessel, if necessary, were obtained using 6 mL to 9
mL of iodixanol (Visipaque 320, GE Healthcare) injected at a rate of 4 mL/s to 6 mL/s.
A positive result was an underlying vascular abnormality accounting for the haemorrhage
Index and comparator tests Multi-detector CTAwas obtained using a 16-detector rowCT scanner (PhillipsMX8000
Infinite Detector Technology) The parameters used included 1mm slice thickness, a 512
x 512 matrix, a pitch of 0.35, and a 20 to 22 cm field of view. Participants were scanned
from the foramen magnum through the top of the skull including the entire cerebral
vasculature. A total of 100 to 120 mL of iohexol (Omnipaque 300; GE Healthcare) was
administered intravenously using a bolus-tracking technique. A positive result was an
underlying vascular abnormality accounting for the haemorrhage
Follow-up Studywithdrawals were explained. There was nomention of uninterpretable scans. There
was no statement regarding adverse effects
Level of expertise of those interpreting the
index test
All CTA images were independently evaluated by 2 neuroradiologists
Notes Multi-detector CTAwas reconstructed into transverse sectionswith a sectionwidth of 0.5
mm from the source images using sagittal and coronalmultiplanar reformations, volume-
rendered technique, and volume-rendered technique after automatic segmentation of a
pre-contrast scan data set. We were able to reclassify cases of moya-moya as ’negatives’
after receiving data from the authors
Table of Methodological Quality
Item Authors’ judgement Description
Representative spectrum? Yes Participants were all prospectively identi-
fied, consecutive cases with acute intra-
parenchymal ICH (with or without exten-
sion into other intracranial spaces) who
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Yoon 2009 (Continued)
were well enough to undergo both CTA
and IADSA, had no contraindications to
CTA or IADSA, and were recruited with
the express purpose of determining the di-
agnostic accuracy of CTA
Acceptable reference standard?
All tests
Yes The reference standard was IADSA for all
participants
Acceptable delay between tests?
All tests
Yes The delay between tests was reported
Partial verification avoided?
All tests
Yes CTA results did not influence who under-
went IADSA
Differential verification avoided?
All tests
Yes All participants underwent IADSA as the
reference standard
Incorporation avoided?
All tests
Yes CTA did not form a part of the reference
standard
Reference standard results blinded?
All tests
Yes IADSA was interpreted independent of
CTA
Index test results blinded?
All tests
Yes CTA was interpreted independent of the
IADSA
Relevant clinical information?
All tests
Unclear There was no statement about whether
those interpreting the CTA and IADSA
were provided with all relevant clinical in-
formation apart from the results of the
competing test
Uninterpretable results reported?
All tests
Unclear There was no statement about whether un-
interpretable test results were encountered
Withdrawals explained?
All tests
Yes Study withdrawals were explained
Index test interpreted by an expert?
All tests
Yes All CTA images were independently evalu-
ated by 2 neuroradiologists
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Zhou 2012
Clinical features and settings The study included patients referred to a tertiary care referral centre at Xi’an Jiaotong
University, China, for investigation of subacute ICH defined as assessment within 1
week of symptom onset. Diagnosis was made according to the 4th National Vascular
Diagnostic Criteria. Patients with blood disorders, space occupying lesions, extracranial
pathology, and meningitis were excluded
Participants 183 participants were enrolled. The mean age was 43.7 years (SD 14.9). Overall age
ranged from 18 to 81. Slightly over half (97/183; 53%) were male. No details were
provided about co-morbidities apart from pre-existing hypertension (present in 52/183;
28%). Anatomical haemorrhage location was lobar in 106 (58%), deep in 55 (30%),
and infratentorial in 22 (12%)
Study design It was unclear whether the case series was prospective or retrospective. All participants
underwent both the index and reference standard
Target condition and reference standard(s) IADSA was performed using a Phillips system. Unit specifications were not provided.
Bilateral selective internal carotid and vertebral artery injections were performed for each
case. Anteroposterior, lateral, and oblique views of each vessel were obtained. A positive
test result was not formally defined
Index and comparator tests The MRA unit was not described. 3-dimensional time of flight imaging was acquired
with a slice thickness of 2.0 mm and a matrix size of 512 x 256. A positive test result
was not formally defined
Follow-up Studywithdrawals were explained. There was nomention of uninterpretable scans. There
was no statement regarding adverse effects
Level of expertise of those interpreting the
index test
MRA images were interpreted by either a radiologist or a neurosurgeon. There is no
statement as to whether the reviewers were blinded to the results of IADSA
Notes -
Table of Methodological Quality
Item Authors’ judgement Description
Representative spectrum? Yes Patients with CT-confirmed subacute (as-
sessed within 1 week of ictus) intracerebral
haemorrhage were included
Acceptable reference standard?
All tests
Yes The reference standard was IADSA for all
participants
Acceptable delay between tests?
All tests
No The authors did not indicate the delay be-
tween MRA and IADSA
Partial verification avoided?
All tests
No MRA results did influence who underwent
IADSA
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Differential verification avoided?
All tests
Yes All participants underwent IADSA as the
reference standard
Incorporation avoided?
All tests
Yes MRA did not form a part of the reference
standard
Reference standard results blinded?
All tests
Unclear The study does not state whether IADSA
was interpreted blinded to theMRA results
Index test results blinded?
All tests
Unclear The study does not state whetherMRAwas
interpreted blinded to the IADSA results
Relevant clinical information?
All tests
Unclear There was no statement about whether
those interpreting the MRA and IADSA
were provided with all relevant clinical in-
formation apart from the results of the
competing test
Uninterpretable results reported?
All tests
Unclear There was no statement about whether un-
interpretable test results were encountered
Withdrawals explained?
All tests
Yes All participants could be accounted for in
the paper
Index test interpreted by an expert?
All tests
No Not all of the results were reviewed by a
neuroradiologist (some were only reviewed
by neurosurgeons)
CT: computed tomography
CTA: computed tomography angiography
IADSA: intra-arterial digital subtraction angiography
ICH: intracerebral haemorrhage
MIP: maximum intensity projection
MRA: magnetic resonance angiography
MRI: magnetic resonance imaging
SD: standard deviation
Characteristics of excluded studies [ordered by study ID]
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Study Reason for exclusion
Awad 1992 Unable to obtain data exclusive to IADSA
Bekelis 2012 Unable to obtain data exclusive to IADSA
Bowen 2007 Review article
Campeau 2012 Review article
Chandra 2012 Review article
Dammert 2004 Study population was SAH or ’atypical’ ICH
Elhammady 2008 IADSA was not the reference standard
Evans 2005 Overall study population of < 20 participants
Fasulakis 2003 Study was performed on patients with known AVMs (the study population was therefore not ICH)
Griffiths 2006 The study population consisted of subarachnoid and intraventricular haemorrhage
Gross 2012 The study population was not ICH
Hünerbein 2003 Unable to obtain data exclusive to IADSA
Kadkhodayan 2012 No CTA or MRA data
Kamel 2013 No comparison between MRA and IADSA
Khosravani 2013 No comparison between MRA and IADSA
Kidwell 2010 Review article
Lee 2007 Unable to obtain data exclusive to IADSA
Leung 2012 Review article
Li 2013 IADSA was not the reference standard
Pott 1992 Index test was not CTA or MRA
Sasiadek 2000 Insufficient information
Sasiadek 2002 Insufficient information
Sha 2008 Unable to obtain data exclusive to IADSA
Truwit 2007 Review article
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(Continued)
Wijman 2012 IADSA was not the reference standard
Zheng 2012 No comparison with IADSA
AVM: arteriovenous malformation
CTA: computed tomography angiography
IADSA: intra-arterial digital subtraction angiography
ICH: intracerebral haemorrhage
MRA: magnetic resonance imaging
SAH: subarachnoid haemorrhage
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D A T A
Presented below are all the data for all of the tests entered into the review.
Tests. Data tables by test
Test
No. of
studies
No. of
participants
1 CTA 8 526
2 MRA 3 401
Test 1. CTA.
Review: Computed tomography angiography or magnetic resonance angiography for detection of intracranial vascular malformations in patients with intracerebral
haemorrhage
Test: 1 CTA
Study TP FP FN TN Sensitivity Specificity Sensitivity Specificity
Delgado Almandoz 2009 41 1 3 63 0.93 [ 0.81, 0.99 ] 0.98 [ 0.92, 1.00 ]
Eshwar Chandra 1998 21 1 3 19 0.88 [ 0.68, 0.97 ] 0.95 [ 0.75, 1.00 ]
Ma 2012 29 0 2 61 0.94 [ 0.79, 0.99 ] 1.00 [ 0.94, 1.00 ]
Murai 1999 5 0 1 25 0.83 [ 0.36, 1.00 ] 1.00 [ 0.86, 1.00 ]
Romero 2009 13 0 0 4 1.00 [ 0.75, 1.00 ] 1.00 [ 0.40, 1.00 ]
Wong 2011 24 1 0 84 1.00 [ 0.86, 1.00 ] 0.99 [ 0.94, 1.00 ]
Yeung 2009 20 3 0 24 1.00 [ 0.83, 1.00 ] 0.89 [ 0.71, 0.98 ]
Yoon 2009 17 0 1 60 0.94 [ 0.73, 1.00 ] 1.00 [ 0.94, 1.00 ]
0 0.2 0.4 0.6 0.8 1 0 0.2 0.4 0.6 0.8 1
47Computed tomography angiography or magnetic resonance angiography for detection of intracranial vascular malformations in patients
with intracerebral haemorrhage (Review)
Copyright © 2014 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Test 2. MRA.
Review: Computed tomography angiography or magnetic resonance angiography for detection of intracranial vascular malformations in patients with intracerebral
haemorrhage
Test: 2 MRA
Study TP FP FN TN Sensitivity Specificity Sensitivity Specificity
Lummel 2012 6 1 0 60 1.00 [ 0.54, 1.00 ] 0.98 [ 0.91, 1.00 ]
Wong 2010 50 1 0 100 1.00 [ 0.93, 1.00 ] 0.99 [ 0.95, 1.00 ]
Zhou 2012 62 1 4 116 0.94 [ 0.85, 0.98 ] 0.99 [ 0.95, 1.00 ]
0 0.2 0.4 0.6 0.8 1 0 0.2 0.4 0.6 0.8 1
A P P E N D I C E S
Appendix 1. MEDLINE search strategy
1. exp basal ganglia hemorrhage/ or intracranial hemorrhages/ or cerebral hemorrhage/ or intracranial hemorrhage, hypertensive/ or
cerebrovascular disorders/
2. ((brain$ or cerebr$ or cerebell$ or intracerebral or intracran$ or parenchymal or intraparenchymal or intraventricular or infratentorial
or supratentorial or basal gangli$ or putaminal or putamen or posterior fossa or hemispher$ or stroke or apoplex$) adj10 (h?emorrhage$
or h?ematoma$ or bleed$)).tw.
3. 1 or 2 or ICH.tw.
4. Magnetic Resonance Angiography/
5. angiography/ or cerebral angiography/
6. Magnetic Resonance Imaging/
7. 5 and 6
8. ((magnetic resonance or MR or MRI or NMR) adj5 (angiogra$ or arteriogra$)).tw.
9. MRA.tw.
10. exp Tomography, X-Ray Computed/
11. angiography/ or cerebral angiography/
12. 10 and 11
13. ((Compute$ tomograph$ or CT or CAT) adj5 (angiogra$ or arteriogra$)).tw.
14. CTA.tw.
15. 4 or 7 or 8 or 9 or 12 or 13 or 14
16. angiography, digital subtraction/
17. angiography/ and (subtraction technique/ or subtraction.tw.)
18. ((digital subtract$ or catheter or cerebral or brain) adj5 (angiogra$ or arteriogra$)).tw.
19. (DSA or IADSA).tw.
20. 16 or 17 or 18 or 19
21. 3 and 15 and 20
22. exp *basal ganglia hemorrhage/di, pa, ra or *intracranial hemorrhages/di, pa, ra or *cerebral hemorrhage/di, pa, ra or *intracranial
hemorrhage, hypertensive/di, pa, ra or *cerebrovascular disorders/di, pa, ra
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23. 15 and 22
24. exp “sensitivity and specificity”/
25. (sensitiv$ or specificity).tw.
26. (predictive adj5 value$).tw.
27. exp diagnostic errors/
28. ((false adj positive$) or (false adj negative$)).tw.
29. (observer adj variation$).tw.
30. (roc adj curve$).tw.
31. (likelihood adj3 ratio$).tw.
32. likelihood function/
33. 24 or 25 or 26 or 27 or 28 or 29 or 30 or 31 or 32
34. 3 and 15 and 33
35. 21 or 23 or 34
36. 20 and 22
37. 3 and 20 and 33
38. 35 or 36 or 37
Appendix 2. EMBASE search strategy
1. basal ganglion hemorrhage/ or brain hemorrhage/ or brain ventricle hemorrhage/ or cerebellum hemorrhage/ or brain hematoma/
2. ((brain$ or cerebr$ or cerebell$ or intracerebral or intracran$ or parenchymal or intraparenchymal or intraventricular or infratentorial
or supratentorial or basal gangli$ or putaminal or putamen or posterior fossa) adj10 (haemorrhage$ or hemorrhage$ or haematoma$
or hematoma$ or bleed$)).tw.
3. 1 or 2 or ICH.tw.
4. magnetic resonance angiography/
5. angiography/ or arteriography/ or exp brain angiography/
6. nuclear magnetic resonance imaging/
7. 5 and 6
8. ((magnetic resonance or MR or MRI or NMR) adj5 (angiogra$ or arteriogra$)).tw.
9. MRA.tw.
10. computed tomographic angiography/
11. angiography/ or arteriography/ or exp brain angiography/
12. computer assisted tomography/ or spiral computer assisted tomography/
13. 11 and 12
14. ((compute$ tomograph$ or CT or CAT) adj5 (angiogra$ or arteriogra$)).tw.
15. CTA.tw.
16. 4 or 7 or 8 or 9 or 10 or 13 or 14 or 15
17. conventional angiography/ or digital subtraction angiography/
18. image subtraction/ or subtraction.tw.
19. angiography/ or arteriography/ or exp brain angiography/
20. 18 and 19
21. ((digital subtract$ or catheter or cerebral or brain) adj5 (angiogra$ or arteriogra$)).tw.
22. (DSA or IADSA).tw.
23. 17 or 20 or 21 or 22
24. 3 and 16 and 23
25. *basal ganglion hemorrhage/di or *brain hemorrhage/di or *brain ventricle hemorrhage/di or *cerebellum hemorrhage/di or *brain
hematoma/di
26. 16 and 25
27. “sensitivity and specificity”/
28. receiver operating characteristic/
29. diagnostic accuracy/
30. exp diagnostic error/
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31. observer variation/
32. “limit of detection”/
33. “diagnostic test accuracy study”.sh.
34. (sensitivity or specificity).tw.
35. (predictive adj3 value$).tw.
36. ((false adj positive$) or (false adj negative$)).tw.
37. observer variation$.tw.
38. (roc adj curve$).tw.
39. (likelihood adj3 ratio$).tw.
40. or/27-39
41. 3 and 16 and 40
42. 24 or 26 or 41
43. 23 and 25
44. 3 and 23 and 40
45. 42 or 43 or 44
Appendix 3. Modified QUADAS methodological items and operational definitions
Methodological variable Operational definition/information required from each study
1. Was the spectrum of patients representative of the patients who
will receive the test in practice?
(Spectrum bias)
Yes: the study population reflects the target population, which we
have defined as prospectively identified, consecutive adults (≥ 16
years of age) with acute intraparenchymal ICH (with or without
extension into other intracranial spaces) who are well enough to
undergo the both tests, have no contraindications to either the
index test or reference standard, and who are recruited with the
express purpose of determining the diagnostic accuracy of the
index test
No: the study population does not match these criteria
Unclear: there is insufficient information provided to compare the
study population to our ideal target population
2. Is the reference standard likely to correctly classify the target
condition?
Yes: IADSA was performed by an expert or experienced opera-
tor. We define ’expert’ as a neuroradiologist and ’experienced’ as
a consultant level (or equivalent) radiologist with ≥ 5 years of
clinical experience. In addition, we will require that, at the very
minimum, the relevant arterial territories in the vicinity of the
haematoma must have been examined
No: IADSAwas not performed by an expert or experienced opera-
tor or the complete arterial territories surrounding the haematoma
were not examined
Unclear: insufficient information is available to evaluate this cri-
terion
3. The delay between the index test and reference standard was
documented
(Disease progression bias)
Yes: the mean or median delay (± standard deviation or interquar-
tile range) between the index test and reference standard is explic-
itly stated
No: the time delay is not reported
Of note, there is no ’appropriate’ time frame between tests per se.
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This is partly because we do not know how long the haematoma
persists in each case. Residual haematoma could obscure the vas-
cular malformation and therefore studies using longer delays be-
tween tests may report varying estimates of accuracy. It is impos-
sible at this point to provide an empirically based ’appropriate’
time frame since we do not yet have the data to analyse this ques-
tion. We aimed to record delay, however, as we wish to establish
empirical evidence of what should be an appropriate time frame
between tests
4. Did the whole sample or a random selection of the sample,
receive verification using a reference standard?
(Partial verification bias)
Yes: every patient or a random selection of patients undergoing
the index test also received the reference standard
No: the index test played a role in selecting who underwent the
reference standard
Unclear: there is insufficient information available to determine if
the index test influenced who underwent the reference standard
5. Did patients receive the same reference standard regardless of
the index test result?
(Differential verification bias)
Yes: all patients undergoing the index test uniformly received the
same reference standard
No: all patients underwent the same index test but underwent
different reference standards
Unclear: there is insufficient detail to tell if every participant in
the analysis underwent the same reference standard
6. Was the reference standard independent of the index test?
(Incorporation bias)
Yes: the index test does not form a part of the reference standard
No: the index test is used in conjunctionwith IADSA as the formal
reference standard
Unclear: there is insufficient information to determine whether
the index tests formed a part of the reference standard
7. Were the reference standard results interpreted without knowl-
edge of the results of the index test?
(Information bias)
Yes: there is an explicit statement that the reference standard was
interpreted blinded to the results of the index test
No: there is an explicit statement that the reference standard was
not interpreted blinded to the results of the index test
Unclear: there is no statement specifically describing how the ref-
erence standard was interpreted in relation to the index test
8. Were the index test results interpreted without knowledge of
the results of the reference standard?
(Information bias)
Yes: there is an explicit statement that the index testwas interpreted
blinded to the reference standard
No: there is an explicit statement that the index test was not
interpreted blinded to the results of the reference standard
Unclear: there is no statement specifically describinghow the index
test was interpreted in relation to the reference standard
9. Were the same clinical data available when test results were
interpreted as would be available when the test is used in practice?
(Information bias)
Yes: there is an explicit statement that the same clinical informa-
tion was available to those interpreting the index test and reference
standard as would be available in routine clinical practice
No: there is an explicit statement that clinical information was
not made available to those interpreting the index test or reference
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standard
Unclear: there is no statement to this effect
10. Were uninterpretable or intermediate test results reported? Yes: uninterpretable index test results are reported and explained
No: if it is explicitly stated or if it is clear from the analysis that
there were unreported intermediate or uninterpretable index tests
results that were not explained by the authors
Unclear: it is not clear if therewere intermediate or uninterpretable
index test results and there is no mention of intermediate or un-
interpretable results in the text
11. Were withdrawals from the study explained? Yes: the authors clearly explain why participants withdrew from
the study, if there is an explicit statement that there were no with-
drawals, or if all patients can be clearly accounted for in the paper
No: if it is clear that patients did withdraw but the authors provide
no explanation as to why this occurred
Unclear: it is impossible to tell whether patients withdrew from
the study
12. Were those interpreting the index test of an appropriate level
of training?
Yes: there is a clear statement that an ’expert’ (a subspeciality neu-
roradiologist) or an ’experienced’ (defined as≥ 5 years of practice
at a consultant level or equivalent) radiologist interpreted the in-
dex test
No: there is an explicit statement that someone other than a neu-
roradiologist or an experienced radiologist interpreted the index
test results
Unclear: there is no statement describing the background of those
who interpreted the index test results or, if a radiologist other
than a neuroradiologist interpreted the index test, their years of
experience are not provided
C O N T R I B U T I O N S O F A U T H O R S
CBJ and RA-SS conceived and designed the review. CBJ, PMW, and RA-SS designed the data collection sheet and the search strategies.
CBJ searched all databases and screened the search results. CBJ organised the retrieval of the papers. Two review authors (CBJ and
PMW or RA-SS) screened papers against the inclusion criteria, appraised the quality of papers, and extracted data from the papers. CBJ
wrote to authors of papers for additional information. CBJ obtained and screened data on unpublished studies. CBJ was responsible
for data management for the review and entered data into RevMan 5.2. CBJ, PMW, AK, and RA-SS analysed and interpreted the data.
CBJ, PMW, AK, and RA-SS wrote the manuscript, which all authors reviewed.
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D I F F E R E N C E S B E TW E E N P R O T O C O L A N D R E V I E W
We calculated sensitivity and specificity for the entire population of studies and evaluated only adults (participants ≥ 16 years of age)
in a sensitivity analysis.
We initially planned to conduct a meta-analyses of study-specific pairs of sensitivity and specificity to create a summary ROC curve in
the SROC space using the random-effects hierarchical SROC model of Rutter and Gatsonis (Rutter 2001), but instead opted for the
bivariate following the review stage (Macaskill 2010).
We used specificity rather than 1-specificity to define the x-axis of the SROC plot.
We used the Metandi package within the Stata Statistical Software version 12.1, rather than Statistical Analysis System (SAS) version
9.2 for Windows, to perform the meta-analysis.
We did not investigate heterogeneity or publication bias because of too few studies (Deeks 2005).
I N D E X T E R M S
Medical Subject Headings (MeSH)
∗Magnetic Resonance Angiography; ∗Tomography, X-Ray Computed; Cerebral Angiography [∗methods]; Cerebral Hemorrhage
[∗etiology]; Intracranial Arteriovenous Malformations [∗complications; diagnosis]; Randomized Controlled Trials as Topic; Sensitivity
and Specificity
MeSH check words
Adolescent; Adult; Female; Humans; Male; Middle Aged
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